Symmetry® Columns Applications Notebook
Symmetry ® Columns Applications Notebook
Symmetry® SymmetryShield™ Symmetry300™ SymmetryPrep™ Intelligent Speed (IS™)
www.waters.com Symmetry® Columns
Setting the Standard for Reproducibility
As today’s chemists establish new Unmatched Year-to-year Reproducibility analytical methods for the latest pharmaceu-
® ® tical and biopharmaceutical products, the Column: Symmetry C18, Instrumentation: Waters Alliance HT 2795 selection of a reproducible HPLC column is 4.6 x 150 mm, 5 µm Waters 996 PDA detector Mobile Phase A: H2O Sampling Rate: 5 pts./sec essential. The selected column needs to Mobile Phase B: MeCN Mobile Phase C: pH 3.75; 100 mM provide the same chromatographic results NH4COOH in H2O Flow Rate: 1.4 mL/min over the life of the new drug product. Isocratic: 30% A; 60% B; 10% C RSD’s for Retention Times Injection Volume: 5.0 µL ® 1. Terbinafine HCl 0.7% Symmetry columns demonstrate superior Temperature: 30 °C reproducibility over many years. Batches Detection: UV @ 233 nm 2. Ibuprofen 0.8% 3. Lovastatin 0.6% randomly selected over the past 5 years 4. Simvastatin 0.7% demonstrate excellent reproducibility in the example shown. Reproducibility is our number one priority in supplying Symmetry® columns. This excellent reproducibility is a result of our commitment Batch 136 (1998) to maintaining the tightest specifications in the HPLC column industry. Symmetry® columns Batch 142 (1998) are engineered with high purity raw materials, tightly controlled manufacturing Batch 149 (1999) processes and column packing procedures that provide today’s scientists with the best, Batch 151 (2000) most reproducible HPLC column available. Batch 156 (2001) Our goal is to supply a family of HPLC columns that you can rely on for rugged and Minutes robust methods. Symmetry® columns let you increase your laboratorys' productivity, and allow easier method transfer between labs and around the globe. Comprehensive Certificate of Analysis A three-page Certificate of Analysis is included with every Symmetry® column. We report both our specifications, which are the tightest in the industry, and the results of the 22 critical tests each column must pass before it carries the Symmetry® brand.
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 1 Table of Contents
Introduction...... 1
Compound Index ...... 3-4
List of Applications ...... 5-8
Applications ...... 9-182
Ordering Information ...... 183-186
Notes ...... 187-192
2 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Compound Index Click in the box, Type desired page number, Then click OK
Acephate ...... 5, 9 Butyl paraben ...... 79, 135, 150 Dichlorprop ...... 14 Acetaminophen ...... 5, 11-13 Butyrophenone ...... 147-148 Diclofenac Sodium ...... 6, 73 Acetanilide ...... 122-123, 147-148 Caffeine ...... 5, 45, 48, 140, 170 2,6-Diethylaniline ...... 10 Acetophenone ...... 147-148 Cafteric acid ...... 125 10,11-Dihydrocarbamezapine ...... 30 2-Acetylfuran ...... 147-148 Calcium Pantothenate ...... 180 Dihydroergotamine mesylate ...... 6, 74 Acifluorfen ...... 14 Captopril ...... 5, 46 Dilitiazem HCL ...... 75-76 Acyclovir ...... 5, 15-17 Captopril Disulfide ...... 46 Dinoseb ...... 14 Alachlor ...... 10 Carbadox...... 5, 47 Diphenoxylate HCL ...... 6, 77 Albuterol ...... 5, 18-19 Catechins...... 48 Diquat ...... 7, 120 Allobarbital ...... 33 Carbamezapine ...... 30 Disopyramide ...... 6, 78 Alpha-Tocopherol (Vitamin E) ...... 179 Carbamezapine-10,11-epoxide ...... 30 Doxepin ...... 6, 29, 79, 173-175 6a-Methyl-17l-hydroxyprogesterone ...... 122-123 Carbaryl ...... 36, 81 Doxycycline ...... 167 2-Amino-7-chloro-5-oxo-5H-[1] Cefixime ...... 5, 49 EDDP (Methadone Metabolite) ...... 99 Benzopyrano[2,3-b]pyridine-3-carbonitrile . . . 122-123 Cefuroxime ...... 5, 50 Enalapril ...... 80 7-Amino Clonazepam ...... 86 Cephalexin ...... 5, 51 Ephedrine ...... 26-27 3-Aminofluoranthene ...... 122-123 Chloramben ...... 14 Epicatechin ...... 48 7-Amino Flunitrazepam ...... 86 Chloramphenicol ...... 5, 52 Epigallocatechin Gallate ...... 48 7-Amino Nitrazepam ...... 86 Chlorcyclizine HCL ...... 65 Estazolam ...... 99 Amitriptyline ...... 173-175, 29 Chlordiazepoxide ...... 6, 53-54 Estradiol ...... 151-152 Amobarbital ...... 33-34 2-Chloro-2,6-diethylacetanilide ...... 10 Estrone ...... 151-152 Amoxapine...... 5, 21 Chlorogenic acid ...... 125 Ethosuximide ...... 153 Amoxicillin ...... 5, 22-24 Chlorpheniramine ...... 6-7, 55, 137, 160 Etodolac ...... 6, 83 Amphetamine ...... 5, 26-27 1-(3-Chlorophenyl)peperazine ...... 171 Fenoprofen ...... 131-132 Ampicillin ...... 5, 25 Cholecalciferol (Vitamin D3) ...... 179 Flunitrazepam ...... 6, 85-86 Angiotensin I ...... 115 Cichoric acid ...... 125 Flurbiprofen ...... 131-132 Angiotensin II ...... 115 Cimetidine ...... 6, 56-58 Folic Acid ...... 8, 181 Antipyrine ...... 5, 31 Clavulanate ...... 23 Furazolidone ...... 161 Atrazine ...... 5, 32, 36, 81, 172 Clobetasol ...... 6, 59 Furosemide ...... 6, 88 AZT ...... 182 Clonazepam ...... 6, 60, 86 Guanosine hydrate ...... 17 β-hydroxyethyltheophylline (I.S.) ...... 45, 140 Cocaethylene ...... 62 Heptanophenone ...... 147-148 Bamethan (I.S.) ...... 19 Cocaine ...... 6, 61-62 Hexanophenone ...... 147-148 Barbital ...... 33 Codeine ...... 6, 11, 63-64, 139 Hydrastine ...... 20 Beclomethasone ...... 5, 35, 59 Codeine-6-Glucuronide (C-6-G) ...... 63-64 Hydrocodone Bitartrate ...... 5, 12 Benomyl ...... 5, 36, 81 Corticosterone ...... 151-152 Hydrocortisone ...... 6, 89, 122-123 Bentazon ...... 14 Cortisone ...... 151-152 Hydrocortisone-21-Acetate ...... 89 Benzoic acid ...... 145-146 Cyanazine ...... 172 4-Hydroxyantipyrine ...... 31 Benzophenone...... 147-148 Cyclizine ...... 6, 65 Hydroxyatrazine ...... 32, 172 Benzoylecgonine ...... 62 Cytochrome C...... 6, 66-69 1-Hydroxybenzotriazole ...... 51 Betamethasone...... 5, 37-38, 149-150 2,4-D ...... 14 Hydroxydesethylatrazine ...... 32 Betamethasone Valerate ...... 149-150 2,4-DB ...... 14 Hydroxydesisopropylatrazine ...... 32 Berberine...... 20 Demoxepam ...... 53-54 7-(2-Hydroxyethyl) Theophylline ...... 169 Bisphenol A ...... 5, 36, 81 Deoxidized (Insulin)...... 91 Ibuprofen ...... 6, 90, 131-132 2-Bromofluorene ...... 122-123 Desamino (Insulin) ...... 91 Imipramine ...... 173, 175 8-Bromoguanosine ...... 122-123 Desethylatrazine ...... 32, 172 Insulin(s) ...... 91-93 BSA ...... 39-42 Desethyldesisopropylatrazine ...... 32 Isorhamnetin ...... 84 Bupropion ...... 5, 43 Desisopropylatrazine ...... 32, 172 Kaempferol ...... 84 Busiperone ...... 5, 44 Dextromethorphan ...... 6, 70-71, 87 Ketamine ...... 124 Butabarbital ...... 33-34 Diazepam ...... 6, 72 Ketoconazole ...... 94 Butalbarbital ...... 33 Dicamba...... 14 Ketoprofen ...... 131-132 Butalbital ...... 34 3,5-Dichlorobenzoic Acid...... 14 Lasix (furosemide) ...... 88
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 3 Compound Index Click in the box, Type desired page number, Then click OK
Leu enkephalin ...... 82 Oxytocin ...... 7, 115 Sulfisoxazole ...... 156-157 Lidocaine HCL ...... 6, 95 Paclitaxel (Taxol) ...... 7, 116-117 2,4,5-T ...... 14 Maleate ...... 160 Papaverine HCL ...... 7, 118 Tamoxifen citrate ...... 162-163 Maleic Acid ...... 80 Paracetamol ...... 7, 119 Taxol ...... 8, 116-117 Maprotiline HCL ...... 6, 97, 171 Paraquat ...... 7, 120 Terconazole ...... 94 MCPA ...... 14 Paraxanthine ...... 45, 140 Terfenadine ...... 8, 164-165 MCPP ...... 14 Peptides...... 7, 121 Testosterone acetate ...... 166 Meclizine HCL ...... 98 Perylene ...... 122-123 Testosterone benzoate ...... 166 Mephenytoin ...... 28 Phencyclidine (PCP) ...... 124 Testosterone enanthate (I.S.) ...... 166 Mephobarbital ...... 33-34 Phenobarbital ...... 28, 30, 33-34 Testosterone Propionate (I.S.) ...... 35, 166 Met enkephalin ...... 82 Phensuximide ...... 153 Tetracaine...... 6, 87 Methadone ...... 7, 99 2-Phenyl-2ethylmalonamide ...... 30 Tetracycline...... 167-168 Methamphetamine ...... 26-27 Phenytoin ...... 30 Theobromine ...... 8, 45, 140, 169-170 Methoxyverapamil ...... 29, 178 Phthalic Acid ...... 146 Theophylline ...... 8, 45, 140, 147-148, 169-170 Methsuximide ...... 153 p-Hydroxyphenobarbital ...... 30 Thiamine Hydrochloride ...... 180-181 Methylparaben ...... 95 Picloram ...... 14 Toluamide ...... 160 Methylphenidate HCL ...... 7, 100 Prednisolone ...... 149-152 2,4,5-TP ...... 14 Metolachlor...... 10 Prednisolone Acetate ...... 149 Trans-Retinol (Vitamin A) ...... 179 Metolachlor-metabolite ...... 10 Prednisone ...... 7, 126 Trazodone ...... 5, 8, 21, 171 Metoprolol ...... 134 Primidone ...... 28, 30 Triamcinolone ...... 122-123 Metoprolol tartrate ...... 7, 101 Procainamide ...... 7, 127-129 Trimethoprim ...... 8, 158-159 Metronidazole ...... 7, 102-103 Prochlorperazine Edisylate ...... 130 Trimipramine ...... 173, 175 Minocycline ...... 167-168 Progesterone ...... 151-152 Tripelennamine ...... 8, 176 Morphine ...... 7, 104 Promethazine HCL ...... 133 Triprolidine HCL ...... 87, 138 Morphine-D3-glucuronide ...... 104 Propiophenone ...... 147-148 Uracil ...... 149, 179 Morphine-D6-glucuronide ...... 104 Propranolol ...... 7, 134-135, 160 Valerophenone ...... 147-148 N-Acetylprocainamide ...... 128-129 Propylparaben ...... 37-38 Verapamil ...... 8, 29, 177-178 N-Propionylprocainamide ...... 128-129 Protriptyline HCL ...... 173 Vitamins ...... 179-181 Nadolol ...... 7, 105 Pseudoephedrine HCL ...... 7, 136-139 Warfarin ...... 6, 87 Nalidixic acid...... 145, 161 Pyridoxal ...... 180 Zidovudine ...... 8, 182 Naloxone ...... 106-109 Pyridoxamine Dihydrochloride ...... 180 Naltrexone ...... 7, 106-109, 114 Pyrodoxine HCL ...... 180 Naphtho(2,3-a)pyrene ...... 122-123 Quercetin ...... 84 Naproxen ...... 7, 90, 110-111 Quinidine sulfate ...... 8, 141 Niacinamide ...... 180 Ranitidine ...... 8, 63-64, 142-144 Nicergoline ...... 7, 112, 181 Riboflavin ...... 180-181 Nifedipine ...... 7, 113 Salbutamol ...... 5, 18-19 Nitrazepam ...... 86 Salicylic acid ...... 8, 145-146 4-Nitrophenol ...... 14 Secobarbital ...... 33-34 Norchlordiazepoxide ...... 53-54 Simazine ...... 172 Nordiazepam ...... 53-54 Succinimide ...... 8, 28, 153 Nordoxepin ...... 29, 174-175 Succinylsulfathiazole ...... 96, 154 Nortriptyline ...... 29, 173-175 Sulfadiazine ...... 97, 154-157 Norverapamil...... 8, 29, 178 Sulfadimethoxine ...... 156-157 Octanophenone ...... 147-148 Sulfadimidine ...... 156-157 O-dichlorobenzene ...... 60 Sulfamerazine ...... 97, 154-157, 159 Oxazepam ...... 53-54 Sulfamethazine ...... 96, 154 Oxolinic Acid ...... 161 Sulfamethoxazole ...... 8, 156-157 Oxprenolol ...... 101, 134 Sulfanilamide ...... 97, 127, 144, 154 Oxycodone ...... 7, 114 Sulfathiazole ...... 97, 154-157
4 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Click on the application titles below to go directly to the desired application For a new search, click on the "List of Applications" bookmarks to the left List of Applications
Acephate in Drinking Water...... 9 Acetamide Herbicides and Metabolites in Drinking Water ...... 10 Acetaminophen and Codeine...... 11 Acetaminophen and Hydrocodone Bitartrate ...... 12 Acetaminophen in Serum ...... 13 Acidic Herbicides in Drinking Water ...... 14 Acyclovir ...... 15,16 Acyclovir in Plasma...... 17 Albuterol (Salbutamol) ...... 18 Albuterol (Salbutamol) in Serum...... 19 Alkaloids in Golden Seal...... 20 Amoxapine & Trazodone ...... 21 Amoxicillin ...... 22 Amoxicillin & Clavulanate Potassium Augmentin Tablet ...... 23 Amoxicillin in an Oral Suspension Formulation...... 24 Ampicillin ...... 25 Amphetamines ...... 26 Amphetamines in Human Urine...... 27 Anticonvulsants...... 28 Antidepressants in Plasma ...... 29 Antiepileptics & Metabolites ...... 30 Antipyrine & Its Metabolites ...... 31 Atrazine & Metabolites in Drinking Water...... 32 Barbiturates ...... 33 Barbiturates in Human Urine...... 34 Beclomethasone ...... 35 Benomyl & Bisphenol A...... 36 Betamethasone...... 37 Betamethasone in Syrup Formulation ...... 38 BSA Tryptic Digest ...... 39 BSA Tryptic Digest - Column Length Effects ...... 40 BSA Tryptic Digest - Flow Rate Effects ...... 41 BSA Tryptic Digest - Gradient Duration Effects ...... 42 Bupropion ...... 43 Busiperone ...... 44 Caffeine and Metabolites in Serum ...... 45 Captopril ...... 46 Carbadox...... 47 Catechins - 4.6 x 20 mm Intelligent Speed™ Separation ...... 48 Cefixime...... 49 Cefuroxime ...... 50 Cephalexin ...... 51 Chloramphenicol ...... 52
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 5 Click on the application titles below to go directly to the desired application For a new search, click on the "List of Applications" bookmarks to the left List of Applications
Chlordiazepoxide & Metabolites...... 53 Chlordiazepoxide & Metabolites in Serum ...... 54 Chlorpheniramine...... 55 Cimetidine ...... 56-58 Clobetasol and Related Compound ...... 59 Clonazepam ...... 60 Cocaine ...... 61 Cocaine & Its Metabolites in Serum ...... 62 Codeine and Its Glucuronide Metabolite in Human Urine ...... 63 Codeine and Its Glucuronide Metabolite in Porcine Plasma ...... 64 Cyclizine & Chlorcyclizine ...... 65 Cytochrome c Tryptic Digest - Column Lifetime Study, Critical Pair Resolution ...... 66 Cytochrome c Tryptic Digest - Pore Size Effects ...... 67 Cytochrome c Tryptic Digest - Recovery Study ...... 68 Cytochrome c Tryptic Digest - Reproducibility Study ...... 69 Dextromethorphan ...... 70 Dextromethorphan in a Cough Syrup ...... 71 Diazepam in Serum - LC/MS ...... 72 Diclofenac Sodium ...... 73 Dihydroergotamine Mesylate ...... 74 Diltiazem HCL ...... 75 Diltiazem HCL -Isolation of Impurities, Transfer from Analytical to Prep ...... 76 Diphenoxylate HCL...... 77 Disopyramide ...... 78 Doxepin in Serum...... 79 Enalapril ...... 80 Endocrine Disruptors in Soil ...... 81 Enkephalins ...... 82 Etodolac...... 83 Flavanoids in Ginko ...... 84 Flunitrazepam ...... 85 Flunitrazepam and Related Compounds ...... 86 Four Drug Mixture: Warfarin, Dextromethorphan, Triprolidine, and Tetracaine ...... 87 Furosemide ...... 88 Hydrocortisone and Related Compunds...... 89 Ibuprofen and Naproxen in Serum ...... 90 Insulin Chain - QC Batch Test for Symmetry 300™ ...... 91 Insulin- Impurity Isolation, Transfer from Analytical to Prep ...... 92 Insulin- Isophase Suspension ...... 93 Ketoconazole...... 94 Lidocaine HCL ...... 95 Lifetime of 3.5 µm Symmetry® Column: 10,000 Injections of Sulfa Drugs ...... 96 Maprotiline HCL...... 97
6 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Click on the application titles below to go directly to the desired application For a new search, click on the "List of Applications" bookmarks to the left List of Applications
Meclizine HCL...... 98 Methadone in Human Urine ...... 99 Methylphenidate HCL ...... 100 Metoprolol Tartrate and Oxyprenolol...... 101 Metronidazole ...... 102,103 Morphine & Its Glucuronide Metabolites in Serum...... 104 Nadolol ...... 105 Naltrexone ...... 106 Naltrexone in Plasma ...... 107 Naltrexone in Plasma - LC/MS ...... 108 Naltrexone in Serum ...... 109 Naproxen ...... 110,111 Nicergoline ...... 112 Nifedipine...... 113 Oxycodone in Serum ...... 114 Oxytocin & Angiotensins in Serum ...... 115 Paclitaxel (Taxol) ...... 116 Paclitaxel (Taxol)- Resolution of Impurities...... 117 Papaverine HCL...... 118 Paracetamol ...... 119 Paraquat & Diquat in Tap Water ...... 120 Peptides- Alberta Peptide Mixture ...... 121 Pharmaceutical Test Mix - 2.1 x 20 mm Intelligent Speed™ Separation...... 122 Pharmaceutical Test Mix - 4.6 x 20 mm Intelligent Speed™ Separation...... 123 Phencyclidine in Human Urine ...... 124 Phenolics in Echinacea ...... 125 Prednisone...... 126 Procainamide in Serum ...... 127 Procainamides at pH 3.0 ...... 128 Procainamides at pH 6.0 ...... 129 Prochlorperazine- Isolation of Degradation Products, Transfer from Analytical to Prep ...... 130 Profens (Gradient) - 4.6 x 20 mm Intelligent Speed™ Separation ...... 131 Profens (Isocratic) - 4.6 x 20 mm Intelligent Speed™ Separation...... 132 Promethazine- Impurities Profile ...... 133 Propranolol in Human Urine...... 134 Propranolol in Serum...... 135 Pseudoephedrine HCL...... 136 Pseudoephedrine HCL & Chlorpheniramine ...... 137 Pseudoephedrine HCL & Triprolidine HCL ...... 138 Pseudoephedrine HCL & Codeine...... 139 Purine Alkaloids ...... 140 Quinidine Sulfate and Related Substance...... 141 Ranitidine...... 142,143
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 7 Click on the application titles below to go directly to the desired application For a new search, click on the "List of Applications" bookmarks to the left List of Applications
Ranitidine in Serum ...... 144 Salicyclic Acid & Related Compounds in Serum ...... 145 Salicyclic Acid & Related Compounds...... 146 Speed Mix - 2.1 x 20 mm Intelligent Speed™ Separation ...... 147 Speed Mix - 4.6 x 20 mm Intelligent Speed™ Separation ...... 148 Steroids...... 149 Steroids in Serum ...... 150 Steroids - 2.1 x 20 mm Intelligent Speed™ Separation ...... 151 Steroids - 4.6 x 20 mm Intelligent Speed™ Separation ...... 152 Succinimides ...... 153 Sulfa Drugs ...... 154,155 Sulfa Drugs - 2.1 x 20 mm Intelligent Speed™ Separation ...... 156 Sulfa Drugs - 4.6 x 20 mm Intelligent Speed™ Separation ...... 157 Sulfamethoxazole Oral Suspension ...... 158 Sulfamethoxazole and Trimethorprim in Serum ...... 159
® Symmetry C18 pH 3 Batch Test...... 160 Synthetic Antibiotics ...... 161 Tamoxifen ...... 162 Tamoxifen, Isolation of Impurities, Transfer from Analytical to Prep Columns ...... 163 Terfenadine ...... 164 Terfenadine and Related Compound ...... 165 Testosterone Esters in Serum ...... 166 Tetracyclines ...... 167 Tetracyclines in Serum ...... 168 Theophylline & Related Compounds ...... 169 Theophylline & Theobromine ...... 170 Trazodone...... 171 Triazine Herbacides in Drinking Water ...... 172 Trycyclic Antidepressants ...... 173 Trycyclic Antidepressants & Metabolites ...... 174 Trycyclic Antidepressants in Plasma ...... 175 Tripelennamine...... 176 Verapamil ...... 177 Verapamil and Norverapamil...... 178 Vitamins: Fat-Soluble ...... 179 Vitamins: Water-Soluble...... 180 Vitamins: Water-Soluble Folic Acid Mixture...... 181 Zidovudine (AZT) ...... 182
8 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Acephate in Drinking Water
HPLC Method Oasis® HLB Extraction Method Conditions for Oasis® HLB Cartridge, 3 cc, 60 mg Part Number WAT094226 Column: SymmetryShield™ RP , 3.9 x 150 mm, 5 µm 8 Prepare Sample: Part Number: WAT200655 To 20 mL sample add 5 g NaCl Adjust to pH 3 with H PO Mobile Phase: H2O/ACN 96:4 3 4 Flow Rate: 1.0 mL/min Condition: Injection volume: 75 µL 3 mL methylene chloride Detection: UV @ 200 nm (0.02 AUFS) Rinse: 3 mL methanol Rinse: 3 mL H2O
Load: 20 mL sample @ 4 mL/min
Elute: 2 mL methylene chloride
Acephate Evaporate and Reconstitute: with 250 µL mobile phase O O H3CS P C H CO N CH 3 3 H % Recovery - contact and systematic Spike Level Spike Level 10 µg/L 5 µg/L organophosphorous insecticide 5 replicates 7 replicates - highly polar, water soluble 91.0% (16.3% RSD) 83.6% (15.0% RSD)
(Source water: chlorinated municipal tap water)
acephate
spiked tap water
nonspiked sample
blank cartridge
0105 MinutesMinutes 15
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 9 Acetamide Herbicides and Metabolites in Drinking Water
HPLC Method Oasis® HLB Extraction Method Conditions for Oasis® HLB Cartridge, 3 cc, 60 mg Part Number WAT094226 ® Column: Symmetry C8 3.9 x 150mm, 5µm Part Number: WAT046970 Condition: 3 mL methanol Mobile Phase A: 10mm phosphate buffer pH 6.8,/acetonitrile 70:30 Mobile Phase B: Acetonitrile Rinse: Gradient: Time Profile 2 mL H2O
(min) %A %B Load: 0 100 0 150 mL sample @ 4 mL/min 20 40 60 Wash: Flow Rate: 1.2 mL/min 1 mL H2O Injection volume: 80 µL Detection: UV @ 214 nm (0.02 AUFS) Elute: 1.2 mL methanol
Evaporate to 0.2 mL Reconstitute to 0.5 ml with reagent H2O
CH2CH3
CH2OCH3 N
COCH2Cl
CH2CH3
Alachlor
Compounds % Recovery Tap Water Tap Water Well Water 2.0 µg/L 200 ng/L 200 ng/L 5 replicates 5 replicates 5 replicates 1. Metolachlor-metabolite* 99.1 (10) 78.9 (22) 88.3 (3.3) 2. 2-Chloro-2,6-diethylacetanilide 98.5 (3.8) 109 (34) 105 (24) 3. 2,6-Diethylaniline 93.3 (11) 80.3 (23) 89.2 (7.8) 4. Alachlor 93.9 (3.2) 90.1 (21) 89.9 (1.2) spiked well water 5. Metolachlor 97.1 (6.6) 93.0 (16) 112 (3.3) (200 ng/L)
1 * 2-[(2-ethyl-6-methylphenyl)amino]1-propanol 3 4 2 5
nonspiked sample
blank cartridge
0 10 Minutes 20
10 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Acetaminophen and Codeine
HPLC Method
® Column: Symmetry C8, 3.9 x 150mm, 5 µm Part Number: WAT046970 Mobile phase: 10mM docusate sodium in methanol/water/THF/phosphoric acid 60:36:4:1 Flow rate: 0.75mL/min Injection volume: 15 µL of 55µg/mL acetaminophen and 35 µg of codeine sample Detection: UV @ 254 nm
USP Tailing Factors 1. 1.09 2. 1.04
1
1. Acetaminophen
2. Codeine
2
0246 81012
MinutesMinutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 11 Acetaminophen and Hydrocodone Bitartrate
HPLC Method
® Column: Symmetry C18, 3.9 x 150mm, 5µm Part Number: WAT046980 Mobile phase: 50 mM Ammonium phosphate, pH 5.8/acetonitrile 85:15 Flow rate: 1.0 mL/min Injection volume: 20 µL of 775µg/mL acetaminophen and 8 µg hydrocodone bitartrate sample Detection: UV @ 214 nm
1. Acetaminophen
2. Hydrocodone Bitartrate
Minutes
12 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Acetaminophen in Serum
HPLC Method Oasis® HLB Extraction Method Oasis® HLB 1 cc/30 mg Extraction Cartridge
™ Part Number WAT094225 Column: SymmetryShield RP8, 3.9 x 150 mm, 5 µm ™ Guard Column: Sentry guard column, 3.9 x 20 mm, 5 µm Condition Part Numbers: Column - WAT200655, Guard - WAT200675 1 mL methanol/1 mL water Mobile phase: 20 mM potassium phosphate, pH 3.0/methanol 97:3) Load Flow rate: 1.0 mL/min 1 mL spiked porcine serum Injection volume: 50 µL of reconstituted porcine serum extract Wash Temperature: 30˚ C 1 mL 5% methanol in water Detection: UV @ 220 nm Elute 1 mL methanol Compounds: 1: Sulfanilamide (I.S.) Evaporate and Reconstitute 40 ˚C under nitrogen stream 2: Acetaminophen 200 µL of 50 µg/mL sulfanilamide (I.S.) in water
H N CH2 HO
O 1. Sulfanilamide (I.S) 2. Acetaminophen
Chromatogram of Serum Extracts: A) Blank B) Spiked Sample
1
0.02 AU
2 Compound Concentration % Recovery %RSD µg/mL (n=6)
B Acetaminophen 0.100 107% 1.5% 0.500 101% 0.40% A
0 4 8 12 MinutesMinutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 13 Acidic Herbicides in Drinking Water
HPLC Method Oasis® HLB Extraction Method Conditions for Oasis® HLB Cartridge, 3 cc, 60 mg Part Number WAT094226 Column: SymmetryShield™ RP 3.9 x 150mm, 5µm 8 Prepare Sample: 75 mL sample, Part Number: WAT200655 adjust to pH 2 with H3PO4 Mobile Phase A: 13 mM phosphate buffer, pH 3.4 Condition: Mobile Phase B: Acetonitrile 3 mL 10:90 methanol/MTBE*
Gradient: Time Profile Risnse: 2 mL methanol (min) %A %B Rinse: 2 mL H2O
08515 Load: 87030 75 mL sample @ 4 mL/min 15 70 30 Wash: 1 mL H O 30 40 60 2 35 10 90 Elute: 2 mL 10:90 methanol/MTBE* Flow Rate: 1.0 mL/min Evaporate to 0.2 mL Injection volume: 75 µL Reconstitute to 0.5 mL with H2O Detection: UV @ 230 nm (0.015 AUFS) * methyl t-butyl ether diethyl ether can be used as an alternative to MTBE
OH
O N Cl OH Cl Cl
Cl + O N N Cl N O O
OH 1. Picloram 2. Dicamba 3. Chloramben 4. 4-Nitrophenol
O Cl N S O Cl OH N O O O O O O O OH OH Cl
5. Bentazon Cl 6. 2,4-D Cl 7. MCPA 8. Dichloroprop 9. 2,4,5-T
O OH Compounds
OH
Cl 1 O 1. Picloram O 2. Dicamba Cl Cl 3. Chloramben 10. MCPP 11. 3,5-Dichlorobenzoic acid 4. 4-Nitrophenol 2 5. Bentazon 3 Cl OH spiked tap water Cl 6. 2,4-D O (400 ng/L) O Cl O 7. MCPA O Cl 8. Dichlorprop 4 5 Cl 9. 2,4,5-T 13 10 OH 6 9 12 15 12. 2,4-DB 13. 2,4,5-TP 7 8 11 14 10. MCPP 11. 3,5-Dichlorobenzoic Cl O OH nonspiked sample + 12. 2,4-DB O N O F 13. 2,4,5-TP O + NN F F O + O OOO O N 14. Acifluorfen O O 15. Dinoseb 0 10 20 MinutesMinutes 30 14. Acifluorfen 15. Dinoseb
14 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Acyclovir
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Part number: WAT046970 Mobile phase: 0.1% glacial acetic acid (aq), pH 3.3 Flow rate: 1.0 mL/min Injection volume: 5 µL of 100 µg/mL sample Detection: UV @ 254 nm
USP Tailing Factors 1. 1.1
1. Acyclovir
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 15 Acyclovir
HPLC Method
™ Column: SymmetryShield RP18, 4.6 x 150 mm, 5 µm Part number: 186000109 Mobile phase: 20 mM, pH 7.0 phosphate buffer/acetonitrile 95:5 Flow rate: 1.0 mL/min Injection volume: 5 µL Detection: UV @ 254 nm
USP Tailing Factors 1. 1.1
1. Acyclovir
Minutes
16 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Acyclovir in Plasma
HPLC Method Oasis® HLB Extraction Method Oasis® HLB 1 cc/30 mg Extraction Cartridge ™ Column: SymmetryShield RP8, 3.9 x 150 mm, 5 µm Part Number WAT094225 Guard Column: Sentry™ guard column 3.9 x 20 mm, 5 µm
Part numbers: Column - WAT200655, Guard - WAT200675 Condition Mobile phase: 20 mM ammonium acetate, pH 5 1 mL methanol/1 mL water Flow rate: 1.0 mL/min Injection volume: 50 µL Load 1 mL spiked plasma Detection: UV @ 250 nm
Wash Compounds: 300 µL water 1. Acyclovir 2. Guanosine hydrate Elute 500 µL 1% glacial acetic acid with 10% methanol
Evaporate and Reconstitute Dilute and add internal standard: 480 µL mobile phase and 20 µL internal standard
1. Acyclovir 2. Guanosine hydrate (I.S.)
Chromatogram of Plasma Extracts: A) Blank B) Spiked Sample
1 Compound Concentration % Recovery %RSD µg/mL (n=6)
Acyclovir 1.0 95.1% 3.4% 0.20 98.3% 5.0%
2
B
0.015AU A
0515 Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 17 Albuterol (Salbutamol)
HPLC Method
® Column: Symmetry C18, 3.9 x 150 mm, 5 µm Part number: WAT046980 Mobile phase: Water/methanol/glacial acetic acid 69:30:1 with 5 mM sodium 1-hexanesulfonate Flow rate: 1.0 mL/min Injection volume: 10 µL of 200 µg/mL salbutamol Detection: UV @ 276 nm
USP Tailing Factors 1. 1.2
1
HO
H N HO CH 3
CH 3 HO 1. Salbutamol
02468
Minutes
18 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Albuterol (Salbutamol) in Serum
HPLC Method Oasis® HLB Extraction Method Oasis® HLB 1 cc/30 mg Extraction Cartridge ® Column: Symmetry C18, 3.9 x 150 mm, 5 µm Part Number WAT094225 Guard Column: Sentry™ guard column, 3.9 x 20 mm, 5 µm Part numbers: Column - WAT046980, Guard - WAT054250 Condition: 1 mL methanol/1 mL water Mobile phase: 5 mM hexanesulfonate and 1% glacial acetic acid in water/1% glacial acetic acid in methanol, 75:25 Load: Flow rate: 1.0 mL/min 1 mL spiked porcine serum with 1.0 µg/mL bamethan (I.S.) Injection volume: 20 µL of reconstituted porcine serum extract
Detection: Fluorescence, Ex = 275 nm, Em = 310 nm Wash: 1 mL 5% methanol in water Compounds: Elute: 1: Salbutamol 1 mL methanol 2: Bamethan (I.S.)
Evaporate and Reconstitute: 40 ˚C under nitrogen stream 200 µL mobile phase
HO
H N HO CH 3
CH 3 HO
1. Salbutamol 2. Bamethan (I.S.)
Chromatogram of Serum Extracts: A) Blank B) Spiked Sample Compound Concentration % Recovery %RSD µg/mL (n=6)
Salbutamol 0.400 98.8% 3.4% 2.00 98.0% 3.5%
1 2
100 mV B
A
0 5 10 15 20 MinutesMinutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 19 Alkaloids in Goldenseal
HPLC Method Oasis® HLB method for alkaloids in Goldenseal Conditions for Oasis® HLB cartridge, 3 cc, 60 mg
® Part Number WAT094226 Column: Symmetry C18, 4.6 x 250 mm, 5 µm Part number: WAT054275 Condition/Equilibrate: Mobile Phase A: 0.1% phosphoric acid 1 mL methanol/1 mL 150 mM K2HPO4 Mobile Phase B: Acetonitrile Gradient: Time Profile Load: (min) %A %B 3 mL of diluted sample 09010 Wash: 13 78 22 1 mL 30% methanol/ 150 mM K2HPO4 40 60 40
Flow Rate: 1.5 mL/min Elute: Injection volume: 10 µL 3 mL methanol Temperature: 35° C Detection: UV @ 330 nm
Herbal tea extract Herbal tea extract after SPE cleanup before SPE cleanup using Oasis® MAX
Sample pre-preparation 100 mg sample is extracted with 25 mL of ethanol:water (70:30) 1 mL of the ethanolic extract is diluted 1:3 with water (~ pH 7)
• Recovery, measured with certified standards at 100 ppm in reagent water, was greater than 85 % for all compounds • All analyses gave results within ± 35 % of the expected values with the exception of the liquid supplement (see goldenseal analysis) • The selective SPE extraction and cleanup procedure provided a convenient analysis of echinacea phenolics in complex matrix such as in herbal tea
hydrastine berberine
0510 Minutes
20 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Amoxapine and Trazodone
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column 3.9 x 20 mm, 5 µm Part numbers: Column - WAT046970, Guard - WAT054250 Mobile phase: 20 mM potassium phosphate pH 7.0/ methanol 35:65 Flow rate: 1.0 mL/min Injection volume: 10 µL of 100 µg/mL amoxapine and 100 µg/mL trazodone Detection: UV @ 254 nm
USP Tailing Factors 1. 1.1 2. 1.4
1. Trazodone
2. Amoxapine
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 21 Amoxicillin
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column 3.9 x 20 mm, 5 µm Part numbers: Column - WAT046970, Guard - WAT054250 Mobile phase: 10 mM sodium acetate, pH 4.0/acetonitrile 96:4 Flow rate: 1.0 mL/min Injection volume: 10 µL of 100 µg/mL sample Detection: UV @ 230 nm
USP Tailing Factors 1. 1.15
1. Amoxicillin
Minutes
22 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Amoxicillin and Clavulanate Potassium Augmentin Tablet
HPLC Method
® Column: Symmetry C8 ,3.9 x 150 mm, 5 µm Part number: WAT046980 Mobile phase: 56 mM sodium phosphate, pH 4.4/methanol 95:5 Flow rate: 1.0 mL/min Injection volume: 10 µL of 100 µg/mL amoxicillin and 25 µg/mL clavulante extracted tablet sample at 10 to 39 µg/mL Detection: UV @ 220 nm
USP Tailing Factors 1. 1.2 2. 1.1
1. Clavulanate
2. Amoxicillin
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 23 Amoxicillinin in an Oral Suspension Formulation
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column 3.9 x 20 mm, 5 µm Part numbers: Column - WAT046970, Guard - WAT054250 Mobile phase: 10 mM sodium acetate, pH 4.0/acetonitrile 96:4 Flow rate: 1.0 mL/min Injection volume: 10 µL of 100 µg/mL sample Detection: UV @ 230 nm
USP Tailing Factors 1. 1.13
1. Amoxicillin
Minutes
24 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Ampicillin
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column 3.9 x 20 mm, 5 µm Part numbers: Column - WAT046970, Guard - WAT054250 Mobile phase: 10 mM sodium acetate, pH 4.0/acetonitrile 92:8 Flow rate: 1.0 mL/min Injection volume: 10 µL of 100 µg/mL sample Detection: UV @ 230 nm
USP Tailing Factors 1. 1.07
1. Ampicillin
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 25 Amphetamines
HPLC Method
™ Column: SymmetryShield RP18, 3.9 x 150 mm, 5 µm, Part Number: 186000108 Mobile phase: 0.1% TFA in Water/acetontrile/methanol 91:7:2 Flow rate: 1.0 mL/min Injection volume: 50 µL Detection: UV @ 210 1. Ephedrine (I.S.)
USP Tailing Factors 1. 1.28 2. 1.32 3. 1.30
2. Amphetamine
3. Methamphetamine
Minutes
26 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Amphetamines in Human Urine
HPLC Method Oasis® HLB Extraction Method Oasis® HLB Extraction Plate, 30 mg/96-well ™ Part Number WAT058951 Column: SymmetryShield RP18, 3.9 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column, 3.9 x 20 mm, 5 µm Part Numbers: Column - 186000108, Guard - 186000107 Conditioning: 1 mL methanol Mobile phase: 0.1% TFA in Water/Acetontrile 90:10 1 mL water Flow rate: 1.0 mL/min Injection volume: 50 µL Load: 2 mL of acidfied spiked human urine Temperature: 30˚ C Detection: UV @ 214 nm (0.14 AUFS) Wash 1: 1 mL 5% methanol with 2% ammonium hydroxide Compounds: Wash 2: 1. Ephedrine 1 mL 20% methanol with 2. Amphetamine 2% ammonium hydroxide
3. Methamphetamine Elute: 0.5 mL 20% methanol with 2% acetic acid
1. Ephedrine (I.S.) 2. Amphetamine 3. Methamphetamine
Chromatogram of A) Spiked Urine, B) Blank Urine
%Recovery (%RSD) Spike Levels: 0.7 µg/mL 3.5 µg/mL
Amphetamine (n=8) 99.3 (4.9) 104.7 (1.8)
FS
U 1 Methamphetamine (n=8) 105.5 (5.8) 100.9 (4.4) 4 A 2
0.1 Amphetamine Interday (n=16) 102.8 (2.7) 3 Amphetamine Interperson (n=16) 98.8 (6.2) 101.8 (3.3) Methamphetamine Interday (n=16) 98.5 (5.4) Methamphetamine Interperson (n=16) 96.4 (11.5) 99.4 (6.3) A Ephedrine (I.S.) (n=8) 89.5 (1.4) B
2 4 6 8 Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 27 Anticonvulsants
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Part number: WAT046970 Mobile phase: 100 mM potassium phosphate, pH 6.9/acetonitrile/water 20:30:50 Flow rate: 1.0 mL/min 1. Succinimide Injection volume: 10 µL of11-160 µg/mL sample Temperature: 30˚ C Detection: UV @ 214 nm
USP Tailing Factors 1. 1.41 2. 1.03 3. 1.11 4. 1.02 2. Primidone 5. 1.07
3. Phenobarbital
4. Mephenytoin
5. Mephobarbital
Minutes
28 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Antidepressants in Plasma
HPLC Method Oasis® HLB Extraction Method Oasis® HLB 1 cc/30 mg Extraction Cartridge ™ Part Number WAT094225 Column: SymmetryShield RP8, 3.9 x 150 mm, 5 µm Part number: WAT200655 Condition: Mobile phase: 100 mM phosphate pH 7.0/acetonitrile/methanol 55:35:10 1 mL methanol/1 mL water
Flow rate: 1.0 mL/min Load: Injection volume: 100 µL acidified plasma sample solution 1 mL of acidified plasma sample solution Temperature: 30˚ C Detection: UV @ 230 nm Wash: 1 mL of 70% methanol, 2% ammonium hydroxide Compounds: Elute: 1. Nordoxepin 0.5 mL of 70% methanol, 2. Nortriptyline 2% acetic acid
3. Norverapamil Evaporate and Reconstitute: 4. Doxepin Not required 5. Amitriptyline 6. Verapamil 7. Methoxyverapamil (I.S.)
1. Nordoxepin 2. Nortriptyline 3. Norverapamil 4. Doxepin
5. Amitriptyline 6. Verapamil 7. Methoxyverapamil (I.S.)
Chromatogram of Plasma Extracts: A) Blank B) Spiked Sample Compound Concentration % Recovery %RSD
µg/mL (n=6) 1 Amitriptyline 1.46 99.9% 1.10% 4 5 0.002 AU 0.29 94.9% 0.60% 2 3 6 Doxepin 1.00 98.4% 0.69% 0.20 98.0% 2.30% 7 Nordoxepin 0.50 92.8% 0.91% 0.10 88.0% 1.33% Nortriptyline 0.62 95.3% 1.29% 0.12 91.1% 1.03% Verapamil 2.50 96.7% 0.63% B. 0.50 98.8% 0.70% A. Norverapamil 1.00 95.9% 0.59% 0.20 98.5% 1.04% 051015 Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 29 Antiepileptics and Metabolites
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column 3.9 x 20 mm, 5 µm Part numbers: Column - WAT046970, Guard - WAT054250 Mobile phase: 100 mM potassium phosphate, pH 6.9/acetonitrile/methanol/water 17:25:5:53 Flow rate: 1.0 mL/min Injection volume: 5 µL of 25µg/mL sample Detection: UV @ 214 nm
USP Tailing Factors 1. NA 5. 1.10 2. NA 6. 1.17 3. 1.13 7. NA 4. 1.17 8. NA 1. 2-Phenyl-2ethylmalonamide 4. Phenobarbital
2. p-Hydroxyphenobarbital 5. Carbamezapine-10,11-epoxide
3. Primidone 6. Carbamezapine
7. 10,11-Dihydrocarbamezapine 8. Phenytoin
Minutes
30 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Antipyrine and Its Metabolite
HPLC Method
™ Column: SymmetryShield RP8,4.6 x 50 mm, 5µm Part Number: 186000224 Mobile phase: 0.1% glacial acetic acid/methanol 85:15 Flow rate: 1.0 mL/min Injection volume: 5 µL solution with antipyrine (240 ng) and 4-hydroxyantipyrine (29 ng) Detection: UV @ 254 nm
1. Antipyrine 1
2
2. 4-Hydroxyantipyrine
2 4
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 31 Atrazine and Metabolites in Drinking Water
HPLC Method Oasis® MCX SPE Method Conditions for Oasis® MCX Cartridge, 6 cc, 150 mg
™ Part Number 186000256 Column: SymmetryShield RP18, 3.9 x 150 mm, 5 µm Part number: 186000108 Prepare Sample: Mobile Phase A: 20 mM Phosphate buffer, pH 6.8 adjust to pH 1.5 with HCI Mobile Phase B: Acetonitrile Condition: 2 mL methanol Gradient: Time Profile Rinse with 2 mL H2O (min) %A %B 0955 Load Sample 2955 Wash #1: 20 25 75 2 mL 0.1 N HCI Flow Rate: 0.8 mL/min Injection volume: 80 µL Wash #2: 2 mL methanol Detection: PDA (215 nm)
Elute: 3 mL methanol (4% NH4OH)
Evaporate and Reconstitute
Compounds (% Recovery - % RSD, n=5) 0.2 µg/L 1.0 µg/L 1. Hydroxydesisopropylatrazine 94 (3) 85 (3) 2. Desethyldesisopropylatrazine 75 (8) 76 (5) 3. Hydroxydesethylatrazine 89 (6) 76 (7) 4. Desisopropylatrazine 79 (4) 83 (2) Drinking water samples (100 mL) were spiked 5. Hydroxyatrazine 107 (7) 101 (2) with the herbicides and adjusted to pH 1.5. The 6. Desethylatrazine 79 (5) 83 (3) samples were then analyzed using 6 cc 7. Atrazine 89 (5) 77 (3) Oasis® MCX cartridges using the protocol for basic compounds
4 5 1
PDA (0.08 AUFS) 6 2 3
7 Spiked Sample
Blank Sample
0 10 20 MinutesMinutes
32 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Barbiturates
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column 3.9 x 20 mm, 5 µm Part numbers: Column - WAT046970, Guard - WAT054250 Mobile phase: 100 mM Potassium phosphate, pH 6.9/acetonitrile/water 20:30:50 Flow rate: 1.0 mL/min Injection volume: 10 µL of 25µg/mL sample Detection: UV @ 214 nm
USP Tailing Factors 1. 1.17 5. 1.11 2. 1.12 6. 1.11 3. 1.14 7. 1.09 1. Barbital 2. Allobarbital 4. 1.10 8. 1.09
3. Phenobarbital 4. Butabarbital
5. Butalbital 6. Amobarbital
7. Mephobarbital 8. Secobarbital
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 33 Barbiturates in Human Urine
HPLC Method Oasis® HLB Extraction Method Oasis® HLB Extraction Plate, 30 mg/96-well Part Number WAT058951 ™ Column: SymmetryShield RP18, 2.1 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column RP , 3.9 x 20 mm, 5 µm Condition: 18 1 mL of methanol Part numbers: Column - 186000111, Guard - 186000107 Mobile phase: 50 mM potassium phosphate, pH 7.0/acetonitrile 71: 29 Equilibrate: 1 mL water Flow rate: 1 mL/min Injection volume: 80 µL urine extract Load: 2 mL water of spiked human urine Temperature: 30 ˚C Detection: UV @ 214 nm (0.350 AUFS) Wash 1: 1 mL of 5% methanol
Wash 2: 1 mL 25% methanol with 2% acetic acid
Elute: 1 mL 35% methanol with 2% ammonium hydroxide
Evaporated: To dryness under N2 at 40˚C
Reconstituted: 300 µL of water
H O N O H C 3 NH
HC3 O
H3C 6. Secobarbital 1. Phenobarbital 2. Butabarbital 3. Butalbital 4. Amobarbital (I.S.) 5. Mephobarbital
Chromatogram of A) Blank Urine, B) Spiked Urine %Recovery (n=8) (%RSD) (n=8) Compound 0.2 µg/mL 1.0 µg/mL
1 1. Phenobarbital 114.3 (1.7) 106.5 (0.5) 2. Butabarbital 95.7 (1.3) 105.5 (0.7) 3. Butalbital 109.5 (0.9) 104.2 (0.9) 2 4. Amobarbital (I.S.) 86.3 (1.7) 3 5. Mephobarbital 92.5 (3.6) 92.4 (1.7) 6. Secobarbital 101.5 (5.2) 94.8 (2.2) 0.350 AUFS 4 5 6
B A
16 0 8 MinutesMinutes
34 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Beclomethasone
HPLC Method
® Column: Symmetry C18,4.6 x 100 mm, 3.5 µm Part number: WAT066220 Mobile phase: Acetonitrile/water 65:35 Flow rate: 1.4 mL/min Injection volume: 15 µL of 0.1 mg/mL of each beclomethasone-dipropionate and testosterone propionate (internal standard) Detection: UV @ 254 nm
USP Tailing Factors 1. 1.1 2. 1.0
1
1. Beclomethasone Dipropionate
2
2. Testosterone Propionate (I.S.)
0 5 10
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 35 Benomyl and Bisphenol A
HPLC Method Oasis® SPE Method for Endocrine Disruptors Conditions for Oasis® HLB Cartridge, 6 cc, 200 mg Part Number WAT106202 ® Column: Symmetry C18, 3.9 x 150 mm, 5 µm Prepare Sample: Part number: WAT046980 adjust to pH 3 Mobile Phase A: 10 mM phosphate, pH 6.8 Condition: Mobile Phase B: Methanol 3 mL MTBE*
Gradient: Time Profile Rinse: 3 mL methanol (min) %A %B Rinse: 3 mL H2O 06040 Load: up to 500 mL sample 20 0 100 Flow Rate: 1.0 mL/min Wash: 3 mL 5% methanol in H2O Injection volume: 100 µL Elute: Detection: PDA (283 nm extracted) 6 mL 10% methanol/MTBEt*
For GC analysis, dry For LC analysis, exchange extract over Na2SO4, to acetonitrile, then then adjust to 1 mL adjust to 1 mL
* methyl t-butyl ether diethyl ether can be used as an alternative to MTBE
1. Benomyl 2. Carbaryl
3. Atrazine 4. Bisphenol A 1 2 4 3 sample
Compounds % RECOVERY ± % RSD blank 1. Benomyl 65 ± 10 2. Carbaryl N/A 3. Atrazine N/A 0 5 10 4. Bisphenol A 83 ± 2
MinutesMinutes 100 ppb spike level in pear
36 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Betamethasone
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column 3.9 mm x 20 mm, 5 µm Part numbers: Column - WAT046970, Guard - WAT054250 Mobile phase: Water/acetonitrile/phosphoric acid 63:37:0.1 Flow rate: 1.0 mL/min Injection volume: 10 µL of 50 µg/mL sample Detection: UV @ 254 nm
USP Tailing Factors 1. 1.12 2. 1.09
1. Betamethasone
2. Propylparaben (internal standard)
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 37 Betamethasone in Syrup Formulation
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column 3.9 x 20 mm, 5 µm Part numbers: Column - WAT046970, Guard - WAT054250 Mobile phase: Water/acetonitrile/phosphoric acid 63:37:0:1 Flow rate: 1.0 mL/min Injection volume: 10 µL of 150 µg/mL sample Detection: UV @ 254 nm
USP Tailing Factors 1. 1.14 2. 1.12
1. Betamethasone
2. Propylparaben (I.S.)
Minutes
Celestone is a registered trademark of Schering Corporation.
38 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. BSA Tryptic Digest
HPLC Method
™ Column: Symmetry300 C18, 4.6 x 50 mm, 5 µm Part number: WAT106209 Mobile phase A: 0.1% TFA in water Mobile phase B: 0.1% TFA in acetonitrile Gradient: Time Profile (min) %A %B 0 100 0 45 70 30 Flow rate: 1.0 mL/min Injection volume: 20 µL Detection: UV @ 214 nm
0.00 20.00 40.00
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 39 BSA Tryptic Digest - Column Length Effects
HPLC Method
™ Column A: Symmetry300 C18, 4.6 x 50 mm, 5 µm ™ Column B: Symmetry300 C18, 4.6 x 150 mm, 5 µm ™ Column C: Symmetry300 C18, 4.6 x 250 mm, 5 µm Part numbers: A: WAT106209 B: WAT106157 C: WAT106151 Mobile phase A: 0.1% TFA in water Mobile phase B: 0.1% TFA in acetonitrile Gradient: Time Profile (min) %A %B 0 100 0 45 70 30 Flow rate: 0.75 mL/min Injection volume: 20 µL (7 µL for 4.6 x 50 mm) Temperature: 35˚C Detection: UV @ 214 nm
A
0.00 20.00 40.00
Minutes
B
0.00 20.00 40.00
Minutes
C
0.00 20.00 40.00
Minutes
40 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. BSA Tryptic Digest - Flow Rate Effects
HPLC Method
™ Column: Symmetry300 C18, 4.6 x 50 mm, 5 µm Part number: WAT106209 Mobile phase A: 0.1% TFA in water Mobile phase B: 0.1% TFA in acetonitrile Gradient: Time Profile (min) %A %B 0 100 0 45 70 30 Injection volume: 20 µL Temperature: 35˚C Detection: UV @ 214 nm
0.3 mL/min
0.00 20.00 40.00
Minutes
0.5 mL/min 0.00 20.00 40.00
Minutes
1.0 mL/min 0.00 20.00 40.00
Minutes
2.0 mL/min 0.00 20.00 40.00
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 41 BSA Tryptic Digest - Gradient Duration Effects
HPLC Method
™ Column: Symmetry300 C18, 4.6 x 50 mm, 5 µm Part number: WAT106157 Mobile phase A: 0.1% TFA in water Mobile phase B: 0.1% TFA in acetonitrile Gradient: Time Profile (min) %A %B 0 100 0 45 70 30 Flow rate: 0.75 mL/min Injection volume: 20 µL Temperature: 35˚C Detection: UV @ 214 nm
Gradient time: 15 min.
0.00 20.00 40.00
Minutes
Gradient time: 25 min. 0.00 20.00 40.00
Minutes
Gradient time: 50 min. 0.00 20.00 40.00
Minutes
Gradient time: 75 min.
0.00 20.00 40.00
Minutes
Gradient time: 150 min.
0.00 20.00 40.00
Minutes
42 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Bupropion
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column 3.9 x 20 mm, 5 µm Part numbers: Column - WAT046970, Guard - WAT054250 Mobile phase: 20 mM potassium phosphate, pH 7.0/methanol 35:65 Flow rate: 1.0 mL/min Injection volume: 10 µL of 20 µg/mL sample Detection: UV @ 254 nm
USP Tailing Factors 1. 105
1. Bupropion
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 43 Busiperone
HPLC Method
™ Column: SymmetryShield RP18, 4.6 x 150 mm, 5 µm Part number: 186000109 Mobile phase: 20 mM phosphate buffer, pH 7.0/acetonitrile 55:45 Flow rate: 1.0 mL/min Injection volume: 5 µL Detection: UV @ 240 nm
USP Tailing Factors 1. 1.08
1. Busiperone
Minutes
44 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Caffeine and Metabolites in Serum
HPLC Method Oasis® HLB Extraction Method Oasis® HLB 1 cc/30 mg Extraction Cartridge ™ Part Number WAT094225 Column: SymmetryShield RP8, 3.0 x 150 mm, 5 µm ™ Guard Column: Sentry guard column, 3.9 x 20 mm, 5 µm Condition Part numbers: Column - WAT094243, Guard - WAT200675 1 mL methanol/1 mL water Mobile phase: 20 mM ammonium acetate, pH 5/acetonitrile, 95:5 Load Flow rate: 0.6 mL/min 1 mL porcine serum with 0.2 µg ß-hydroxyethyltheophylline (I.S.) Injection volume: 20 µL of reconstituted porcine serum extract
Temperature: 25˚ C Wash Detection: UV @ 273 nm 1 mL water
Elute Compounds: 1 mL methanol 1: Theobromine 2: Paraxanthine Evaporate and Reconstitute 40 ˚C under nitrogen stream 3: Theophylline 200 µL mobile phase 4: β-hydroxyethyltheophylline (I.S.) 5: Caffeine
1. Theobromine 2. Paraxanthine 3. Theophylline
O CH2CH2OH
H3C N O CH2 N
H3C N N N O N
N CH3 O N
CH3
4. ß-hydroxyethyltheophylline (I.S.) 5. Caffeine
Chromatogram of Serum Extracts: A) Blank B) Spiked Sample
Compound Concentration % Recovery %RSD 1 µg/mL (n=6)
Theobromine 0.100 103.0% 3.4% 3 0.500 104.0% 2.4% 0.03 AU 2 Paraxanthine 0.100 101.0% 6.2% 0.500 98.9% 2.3% 5 Theophylline 0.100 100.0% 5.2% 0.500 101.0% 2.1% 4 Caffeine 0.100 92.6% 4.4% 0.500 97.5% 3.2% B
A
0 5 10 15
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 45 Captopril
HPLC Method
® Column: Symmetry C18, 3.9 x 150 mm, 5 µm Part number: WAT046980 Mobile phase: 0.1% phosphoric acid in water/methanol 60:40 Flow rate: 1.0 mL/min Injection volume: 10 µL of 200 µg/mL captopril and 20 µg/mL of captopril disulfide Temperature: 40˚ C Detection: UV @ 220 nm
USP Tailing Factors: 1. 1.0 2. 1.2
1. Captopril
Minutes
46 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Carbadox
HPLC Method
® Column: Symmetry C18, 4.6 x 100 mm, 3.5 µm Part number: WAT066220 Mobile phase: 20 mM ammonuim acetate, pH 5.0/Acetonitrile 85:15 Flow rate: 1.4 mL/min Injection volume: 15 µL of 0.025 mg/mL Temperature: 30˚ C Detection: UV @ 254 nm
USP Tailing Factors 1. 1.1
1. Carbadox
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 47 Catechins - 4.6 x 20 mm Intelligent Speed™ Separation
HPLC Method
® ™ Columns: Symmetry C18, 4.6 x 20 mm, 3.5 µm IS ™ ™ SymmetryShield RP18, 4.6 x 20 mm, 3.5 µm IS Part numbers: Symmetry - 186002090, Shield - 186002092 Mobile phase A: 0.1% HCOOH in Water Mobile phase B: 0.1% HCOOH in MeOH Gradient: Time Profile (min) %A %B 0.0 100 0 4.0 60 40 Flow rate: 3.0 mL/min
Injection volume: 10 µL OH ˚ Temperature: 30 C O CH2 OH
Detection: UV @ 280 nm H3C N OH HO O OH N
Compounds: HO O O N OH O N OH OH 1. Caffeine O OH 2. Epicatechin CH3 OH OH 3. Epigallocatechin Gallate OH 1. Caffeine 2. Epicatechin 3. Epigallocatechin Gallate
1
™ SymmetryShield RP18
2 3 t0= 0.13 min Max psi= 2225
0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00
Minutes
1
® Symmetry C18 3 2
t0= 0.13 min Max psi= 2111
0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00
Minutes
48 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Cefixime
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column 3.9 x 20 mm, 5 µm Part numbers: Column - WAT046970, Guard - WAT054250 Mobile phase: 10 mM sodium acetate, pH 3.8/acetonitrile 80:20 Flow rate: 1.0 mL/min Injection volume: 10 µL of 100 µg/mL extracted suspension sample Detection: UV @ 254 nm
USP Tailing Factors 1. 1.27
1. Cefixime
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 49 Cefuroxime
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column 3.9 x 20 mm, 5 µm Part numbers: Column - WAT046970, Guard - WAT054250 Mobile phase: 5 mM sodium acetate, pH 3.8/acetonitrile 80:20 Flow rate: 1.0 mL/min Injection volume: 10 µL of 100 µg/mL sample Detection: UV @ 254 nm
USP Tailing Factors 1. 1.44
1. Cefuroxime
Minutes
50 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Cephalexin
HPLC Method
® Column: Symmetry C18, 3.0 x 150 mm, 5µm Part number: WAT054200 Mobile phase: 1.25% glacial acetic acid in water/methanol 88:12 Flow rate: 0.6 mL/min Injection volume: 400 µL of cephalexin (1 mg/mL) and 200 µL of 1-hydroxybenzotriazole (Internal standard, 1 mg/mL) Detection: UV @ 254 nm
USP Tailing Factors 1. 1.4 2. 1.2
1. 1-hydroxybenzotriazole (IS) 2
1
2. Cephalexin
0 10 Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 51 Chloramphenicol
HPLC Method
® Column: Symmetry C8, 3.9 x 150mm, 5 µm Guard Column: Sentry™ Guard Column 3.9 x 20 mm, 5 µm Part numbers: Column - WAT046970, Guard - WAT054250 Mobile phase: Water/methanol/glacial acetic acid 55:45:0.1 Flow rate: 1 mL/min Injection volume: 10 µL of 100 µg/mL Detection: UV @ 280 nm
USP Tailing Factors 1. 1.1
1. Chloramphenicol
Minutes
52 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Chlordiazepoxide and Metabolites
HPLC Method
® Column: Symmetry C18,3.0 x 150 mm, 5 µm Part number: WAT054200 Mobile phase: 20 mM Potassium phosphate pH 7.0/methanol/acetonitrile 49:28:23 Flow rate: 0.59 mL/min Injection volume: 5 µL of 40 74 µg/mL Detection: UV @ 240 nm
USP Tailing Factors 1. 1.1 2. 1.2 3. 1.1 1. Norchlordiazepoxide 4. 1.2 5. 1.1
2. Oxazepam
1
3. Noradiazepam
3 4 5 4. Chlordiazepoxide 2
impurity
5 10
Minutes 5. Demoxepam
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 53 Chlordiazepoxide and Metabolites in Serum
HPLC Method Oasis® HLB Extraction Method Oasis® HLB 1 cc/30 mg Extraction Cartridge ® Part Number WAT094225 Column: Symmetry C18, 3.9 x 150 mm, 5 µm ™ Guard Column: Sentry guard column, 3.9 x 20 mm, 5 µm Condition: 1 mL methanol/1 mL water Part numbers: Column - WAT046980, Guard - WAT054225 Mobile phase: 20 mM Potassium phosphate, pH 7.0/acetonitrile/methanol 56:21:23 Load: 1 mL spiked porcine serum Flow rate: 1.0 mL/min with 1.5 µg/mL demoxepam (I.S.) Injection volume: 20 µL of reconstituted porcine serum extract Wash: Detection: UV @ 240 nm 1 mL 5% methanol in water
Compounds: Elute: 1 mL methanol 1: Norchlordiazepoxide 2: Oxazepam Evaporate and Reconstitute: 40 ˚C under nitrogen stream 3: Nordazepam 200 µL of 20 mM potassium phosphate pH 4: Chlordiazepoxide 7/methanol 80:20 (v/v) 5: Demoxepam (I.S.)
H N O
Cl N
1. Norchlordiazepoxide 2. Oxazepam 3. Nordazepam 4. Chlordiazepoxide 5. Demoxepam
Chromatogram of Serum Extracts: A) Blank B) Spiked Sample
1
Compound Concentration % Recovery %RSD µg/mL (n=6) 0.002 AU 1. Norchlordiazepoxide 0.200 97.8% 4.3% 5 2 3 0.040 96.5% 5.5% 4 2. Oxazepam 0.200 104.0% 2.6% 0.040 90.0% 2.5% 3. Nordazepam 0.200 101.0% 3.0% B 0.040 98.9% 1.2%
A 4. Chlordiazepoxide 0.200 90.0% 2.4% 0.040 100.0% 4.1% 5 10 15 20 MinutesMinutes
54 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Chlorpheniramine
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Part number: WAT046970 Mobile phase: 50 mM potassium phosphate, pH 3.0/ acetonitrile 80:20 Flow rate: 1.0 mL/min Injection volume: 5 µL of 120 µg/mL sample Detection: UV @ 261 nm
USP Tailing Factors 1. 1.33
1. Chlorpheniramine Maleate
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 55 ™ Cimetidine- (SymmetryShield RP18)
HPLC Method
™ Column: SymmetryShield RP18, 4.6 x 250 mm, 5 µm Part number: 18600012 Mobile phase: 0.3 mL phosphoric acid, methanol/water 18:82 Flow rate: 1.8 mL/min Injection volume: 50 µL Detection: UV @ 220 nm
USP Tailing Factors 1. 1.22
1. Cimetidine
01 23 Minutes
56 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Cimetidine - Ion-Pair Separation
HPLC Method
® Column: Symmetry C18, 3.9 x 150 mm, 5 µm Part number: WAT046980 Mobile phase: 6.6 mM sodium 1-hexanesulfanate, 0.04% phosphoric acid in water/methanol 76:24 Flow rate: 1.0 mL/min Injection volume: 10 µL of 100 µg/mL Detection: UV @ 220 nm
USP Tailing Factors 1. 1.2
1. Cimetidine
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 57 ® Cimetidine- (Symmetry C18 )
HPLC Method
® Column: Symmetry C18, 3.9 x 150 mm, 5 µm Part number: WAT046980 Mobile phase: 0.03% Phosphoric acid in water/methanol 90:10 Flow rate: 1.0 mL/min Injection volume: 10 µL injection of 10 µg/mL Detection: UV @ 220 nm
USP Tailing Factors 1. 1.2
1
1. Cimetidine
1 2 3 4
Minutes
58 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Clobetasol and Related Compound
HPLC Method
™ Column: SymmetryShield RP18,4.6 x 150 mm, 5 µm Part number: 186000109 Mobile phase: Acetonitrile/water/methanol 48:42:10 Flow rate: 1.0 mL/min Injection volume: 10 µL Detection: UV @ 240 nm
USP Tailing Factors 1. 1.07 2. 1.05
1. Clobetasol
2. Beclomethasone
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 59 Clonazepam
HPLC Method
® Column: Symmetry C18, 4.6 x 250 mm, 5 µm Part number: WAT054275 Mobile phase: Water/methanol/acetonitrile 40:30:30 Flow rate: 1.5 mL/min Injection volume: 25 µL of sample with 40 µg/mL of clonazepam and 80 µL/mL of o-dichlorobenzene (internal standard) Detection: UV @ 254 nm
USP Tailing Factors 1. 1.08 2. 1.04
1. Clonazepam
2. O-dichlorobenzene (IS)
Minutes
60 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Cocaine
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column 3.9 x 20 mm, 5 µm Part numbers: Column - WAT046980, Guard - WAT054225 Mobile phase: 20 mM potassium phosphate, pH 2.18/methanol 75:25 Flow rate: 1.0 mL/min Injection volume: 5 µL of 200 µg/mL sample Detection: UV @ 254 nm
USP Tailing Factors 1. 1.4
Me N O OMe
O O 1. Cocaine
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 61 Cocaine and its Metabolites in Serum
HPLC Method Oasis® HLB Extraction Method Oasis® HLB 1 cc/30 mg Extraction Cartridge ® Column: Symmetry C18, 3.9 x 150 mm, 5 µm Part Number WAT094225 Guard Column: Sentry™ guard column, 3.9 x 20 mm, 5 µm Condition Part numbers: Column - WAT046970, Guard - WAT054250 1 mL methanol/1 mL water Mobile phase A: 20 mM potassium phosphate, pH 7 Mobile phase B: Methanol Load Gradient: Time Profile 1 mL serum spiked porcine sample with 20 µL phosphoric acid (min) %A %B
07822 Wash 8.5 78 22 1 mL 5% methanol in water 8.6 42 58 30 42 58 Elute 1 mL methanol Flow rate: 1.0 mL/min
Injection volume: 1 mL of reconstituted porcine serum extract Evaporate and Reconstitute Detection: UV @ 235 nm 40 ˚C under nitrogen stream 250 µL water:methanol 80:20 (v/v)
Me Me N O N O OMe O
O O O O 1. Benzoylecgonine 2. Cocaine 3. Cocaethylene
Chromatogram of Serum Extracts: A) Blank B) Spiked Sample
2
3 1 Compound Concentration % Recovery %RSD µg/mL (n=6)
1. Benzoylecgonine 2.00 93.7% 1.7% 0.40 93.6% 2.2% 2. Cocaine 2.00 98.0% 1.1% 0.40 93.4% 2.9% 3. Cocaethylene 2.50 97.7% 2.8% 0.01. AU B 0.50 98.2% 5.1% A
5 10 15 20 25 Minutes
62 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Codeine and Its Glucuronide Metabolite in Human Urine
HPLC Method Oasis® MCX Extraction Method Oasis® MCX Extraction Cartridge, 3 cc/60 mg ® Column: Symmetry C18, 2.1 x 150 mm, 3.5 µm Part Number 186000254 Guard Column: Symmetry® C , 2.1 x 10 mm, 3.5 µm 18 Load Part numbers: Column - 186000174, Guard - 186000169 3 mL acidified spiked human urine Mobile phase: Methanol/Acetonitrile/0.05% TFA in water 5:5:90 Flow rate: 0.3 mL/min No Conditioning Injection volume: 80 µL urine extract Temperature: 30˚ C Wash 1 2 mL 0.1N hydrochloric acid Detection: UV @ 220 nm (0.04 AUFS)
Wash 2 Compounds: 2 mL methanol 1. Ranitidine (I.S.) Elute 2. Codeine-6-Glucuronide (C-6-G) 2 mL 5% ammonium hydroxide 3. Codeine with 95% methanol
After elution, the extract is diluted 1:3 with water for HPLC analysis
H3CO
CH3O
O H
N-CH3 O H O OH C O OH NCH3 O HO OH OH
1. Ranitidine 2. Codeine-6-Glucuronide 3. Codeine (C-6-G)
Compound % Recovery %RSD 0.12 µg/mL 0.6 µg/mL Chromatogram of Urine Extracts: A) Blank B) Spiked Sample Codeine (n=3) 88.5 (2.7) 99.5 (1.2) Codeine-6-Glucuronide (n=3) 99.3 (5.4) 98.7 (0.4) Codeine Interday (n=6) 102.5 (3.5) 105.4 (4.0) Codeine Interperson (n=9) 91.6 (7.1) 104.1 (5.4) 3 C-6-G Interday (n=6) 116.1 (9.4) 111.5 (3.3) C-6-G Interperson (n=9) 102.4 (7.7) 107.4 (7.3)
2 0.04 AUFS spiked sample
1
0 5 10 MinutesMinutes nonspiked sample
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 63 Codeine and Its Glucuronide Metabolite in Porcine Plasma
HPLC Method Oasis® MCX Extraction Method
® ® Oasis MCX Extraction Cartridge, 3 cc/60 mg Column: Symmetry C18, 2.1 x 150 mm, 3.5 µm ® Part Number 186000254 Guard Column: Symmetry C18, 2.1 x 10 mm, 3.5 µm Part numbers: Column - 186000174, Guard - 186000169 No Conditioning Mobile phase: Methanol/Acetonitrile/0.05% TFA in water 5:5:90
Flow rate: 0.3 mL/min Load Injection volume: 80 µL urine extract 3 mL acidified plasma sample Temperature: 30˚ C Detection: UV @ 220 nm (0.04 AUFS) Wash 1 2 mL 0.1N hydrochloric acid Compounds: 1. Ranitidine (I.S.) Wash 2 2. Codeine-6-Glucuronide (C-6-G) 2 mL methanol 3. Codeine Elute 2 mL 5% ammonium hydroxide with 95% methanol
After elution, the extract is diluted 1:3 with water for HPLC analysis
H3CO
CH3O
O H
N-CH3 O H O OH C O OH NCH3 O HO OH OH
1. Ranitidine 2. Codeine-6-Glucuronide 3. Codeine (C-6-G)
Chromatogram of Plasma Extracts: A) Blank B) Spiked Sample % Recovery(n=3) %RSD(n=3) Spike Level: 0.12 µg/mL 0.6 µg/mL
Codeine 95.4 (5.0) 103.4 (0.9) Codeine-6-Glucuronide 106.8 (1.9)1 04.6 (1.3)
Minutes
64 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Cyclizine and Chlorcyclizine
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column 3.9 x 20 mm, 5 µm Part numbers: Column - WAT046970, Guard - WAT054250 Mobile phase: 7.4 mM sodium 1-heptanesulfonate in water/acetonitrile 65:35 Flow rate: 1.0 mL/min Injection volume: 8 µL of 100 µg/mL sample Detection: UV @ 230 nm
USP Tailing Factors 1. 1.28 2. 1.28
1. Cyclizine
2. Chlorcyclizine HCL
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 65 Cytochrome c Tryptic Digest - Column Lifetime Study, Critical Pair Resolution
HPLC Method
™ Column: Symmetry300 C18, 3.9 x 150 mm, 5 µm Part number: WAT106154 Mobile phase A: 0.1% TFA water/acetonitrile 90:10 Mobile phase B: 0.1% TFA water/acetonitrile 40:60 Gradient: Time Profile (min) %A %B 0 100 0 45 34 66 Flow rate: 0.75 mL/min Injection volume: 20 µL Temperature: 35˚C Detection: UV @ 214 nm
Minutes Minutes
66 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Cytochrome c Tryptic Digest - Pore Size Effects
HPLC Method
® Column: Symmetry C18, 4.6 x 150 mm, 5 µm, 100Å ™ Guard Column: Symmetry300 C18, 4.6 x 150 mm, 5 µm, 300Å Part numbers: Column - WAT045905, Guard - WAT106157 Mobile phase A: 0.1% TFA in Water Mobile phase B: 0.1% TFA in Acetonitrile Gradient: Time Profile (min) %A %B 0 100 0 50 70 30 Flow rate: 0.75 mL/min Injection volume: 20 µL Temperature: 35˚C Detection: UV @ 214 nm
® Symmetry C18, 4.6 x 150 mm, 5 µm, 100Å
0.00 20.00 40.00 Minutes
™ Symmetry300 C18, 4.6 x 150 mm, 5 µm, 300Å
0.00 20.00 40.00 Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 67 Cytochrome c Tryptic Digest - Recovery Study
HPLC Method
™ Column: Symmetry300 C18, 4.6 x 50 mm, 5 µm Part number: WAT106209 Mobile phase A: 0.1% TFA in Water Mobile phase B: 0.1% TFA in Acetonitrile Gradient: Time Profile (min) %A %B 0 100 0 45 70 30 Flow rate: 1.0 mL/min Injection volume: 20 µL Temperature: 35˚C Detection: UV @ 214 nm
First Run
Second Run
Minutes TFA Blank Injection
68 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Cytochrome c Tryptic Digest - Reproducibility Study
HPLC Method
™ Column: Symmetry300 C18, 3.9 x 150 mm, 5 µm Part number: WAT106154 Mobile phase A: 0.05% TFA in Water Mobile phase B: 0.1% TFA in Acetonitrile Gradient: Time Profile (min) %A %B 0 100 0 45 72 28 Flow rate: 1.0 mL/min Injection volume: 20 µL Temperature: 35˚C Detection: UV @ 220 nm
Batch 107
Batch 106
Batch 104
Batch 103
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 69 Dextromethorphan
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column 3.9 x 20 mm, 5 µm Part numbers: Column - WAT046970, Guard - WAT054250 Mobile phase: 23 mM ammonium nitrate, pH 3.4/acetonitrile 30:70 Flow rate: 1.0 mL/min Injection volume: 20 µL of 100 µg/mL sample Detection: UV @ 254 nm
USP Tailing Factors 1. 0.98
1 1. Dextromethorphan
Minutes
70 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Dextromethorphan in a Cough Syrup
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column 3.9 x 20 mm, 5 µm Part numbers: Column - WAT046970, Guard - WAT054250 Mobile phase: 23 mM ammonium nitrate, pH 3.4/acetonitrile 30:70 Flow rate: 1.0 mL/min Injection volume: 20 µL of 100 µg/mL sample Detection: UV @ 254 nm
USP Tailing Factors 1. 0.95
1. Dextromethorphan
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 71 Diazepam in Serum - LC/MS
HPLC Method Oasis® HLB Extraction Method Oasis® HLB 1 cc/30mg Extraction Cartridge ® Part Number WAT04225 Column: Symmetry C18, 2.1 x 100 mm, 3.5 µm
Part number: WAT058965 Condition: Mobile phase: 2 mM Ammonium Acetate/Acetonitrile/Formic Acid 65:35:0.1 1 mL methanol/1 mL water Flow rate: 200 µL/min
Injection volume: 10 µL Load: MS: Micromass Quattro LC 1 mL porcine serum Ion Mode: ES+ Cone Voltage: 45 V Wash: Collision Energy: 25 eV 1 mL 5% methanol in water
Elute: 1 mL methanol
Evaporate and Reconstitute: 40˚ C under nitrogen stream, 200 µL mobile phase 2.28 2.26 2.27 39 100 100 100 A B C Diazepam
CH3 N O
% % % Cl N
0 Time 0 Time 0 Time 1.00 2.00 3.00 4.00 1.00 2.00 3.00 1.00 2.00 3.00 4.00
Figure 4: MRM Chromatograms under optimum conditions of pure diazepam standard at (A) 0.2ng/mL (LOD) and (B) 5.0ng/mL and (C) a processed human plasma sample with a low concentration of diazepam (calculated as 0.75ng/mL) 285.1 100 Precursor (m/z) 285 % Compound 3 name: Diazepam 287.1 Coefficent of Determination: 0.998439 Calibration curve: 150.210* x + -0.398957 Response type: External Std., Area Curve type: Linear, Origin: Exclude, Weighting: 1/x Axis trans: None 0 m/z 60 80 100 120 140 160 180 200 220 240 260 280 300 320 340 Figure 1: Background-subtracted electrospray mass spectrum of pure diazepam standard (5µg), under optimum conditions. 771 Chromatographed as described above to remove contaminants.
154.1 100 Response 165 Product 285.4 (m/z) 193.4 222.4 Response 154 % 228.2 3.5 257.3
-0.399 ng/mL 0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 182.0 -0.399 ng/mL 167.0 0.0 0.5 1.0 1.5 2.0 2.5 3.0 4.0 4.5 5.0 0 m/z 60 80 100 120 140 160 180 200 220 240 260 280 300 320 340 Figure 3: Calibration curve with triplicate injections for each point and demonstrating LOQ at 0.2ng/mL Figure 2: Background-subtracted electrospray product tion spectrum of pure diazepam standard (5µg), under optimum conditions. Chromatographed as described above to remove contaminants.
72 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Diclofenac Sodium
HPLC Method
™ Column: SymmetryShield RP18, 4.6 x 150 mm, 5 µm Part number: 186000109 Mobile phase: 20 mM phosphate buffer, pH 7.0/acetonitrile 65:35 Flow rate: 1.0 mL/min Injection volume: 5 µL Detection: UV @ 220 nm
USP Tailing Factor 1. 1.18
1 1. Diclofenac
0 1 2 3 4 5 6
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 73 Dihydroergotamine Mesylate
HPLC Method
® Column: Symmetry C18, 3.9 x 150 mm, 5 µm Part number: WAT046980 Mobile phase: 50 mM ammonium phosphate, pH 5.8/Acetonitrile 35:65 Flow rate: 1.0 mL/min Injection volume: 10 µL of 100 µg/mL dihydroergotamine mesylate Detection: UV @ 281 nm
USP Tailing Factors 1. 1.1
1. Dihydroergotamine mesylate
Minutes
74 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Diltiazem HCL
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column 3.9 x 20 mm, 5 µm Part numbers: Column - WAT046970, Guard - WAT054250 Mobile phase: 100 mM sodium acetate, 5mM camphosulfonic acid, pH 6.2/acetonitrile/methanol 40:30:30 Flow rate: 1.0 mL/min Injection volume: 10 µL of 50 µg/mL sample Detection: UV @ 254 nm
USP Tailing Factors 1. 1.08
1. Dilitiazem HCL
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 75 Diltiazem HCL- Isolation of Impurities, Transfer from Analytical to Prep Columns
HPLC Method
® Column: A. Symmetry C18, 3.9 x 150 mm, 5 µm ™ B. SymmetryPrep C18, 7.8 x 150 mm, 7 µm ™ C. SymmetryPrep C18, 19 x 150 mm, 7 µm Part numbers: A. WAT046980 B. WAT066288 C. WAT066240 Mobile phase: Acetonitrile/0.1% TFA in water 30:70 Flow rates: A. 0.7 mL/min B. 2.8 mL/min C. 16.6 mL/min Injection volume: Diltiazem: A. 0.5 mg B. 2.0 mg C. 11.9 mg Detection: UV @ 280 nm
® A. Symmetry C18 ,5 µm, 3.9 mm x 150 mm
1. Diltiazem Hydrochloride
™ B. SymmetryPrep C18 ,7 µm, 7.8 mm x 150 mm
™ C. SymmetryPrep C18 ,7 µm, 19 mm x 150 mm
Minutes
76 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Diphenoxylate HCL
HPLC Method
® Column: Symmetry C18, 3.9 x 150 mm, 5 µm Part number: WAT046980 Mobile phase: 50 mM potassium phosphate, pH 6.0/acetonitrile 30:70 Flow rate: 1.0 mL/min Injection volume: 10 µL of 100 µg/mL Diphenoxylate hydrochloride Detection: UV @ 210 nm
USP Tailing Factors 1. 1.3
1. Diphenoxylate HCL
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 77 Disopyramide
HPLC Method
® Column: Symmetry C18,3.9 x 150 mm, 5 µm Part number: WAT046980 Mobile phase: 50 mM potassium phosphate, pH 7.0/methanol 70:30 Flow rate: 1.0 mL/min Injection volume: 20 µL of 100 µg/mL sample Detection: UV @ 254 nm
USP Tailing Factors 1. 1.3
1. Disopyramide
Minutes
78 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Doxepin in Serum
HPLC Method Oasis® HLB Extraction Method Oasis® HLB 1 cc/30 mg Extraction Cartridge ™ Part Number WAT094225 Column: SymmetryShield RP8, 3.9 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column, 3.9 x 20 mm, 5 µm Condition Part numbers: Column - WAT200655, Guard - WAT200675 1 mL methanol/1 mL water Mobile phase: 20 mM potassium phosphate, pH 7/methanol 38:62 Load Flow rate: 1.0 mL/min 1 mL spiked porcine serum Injection volume: 20 µL of reconstituted porcine serum extract Temperature: 30˚ C Wash 1 mL 5% methanol in water Detection: UV @ 254 nm Elute 1 mL methanol with 5 µg Compounds: butyl paraben (I.S.) 1: Butyl paraben (I.S.) 2: Doxepin Evaporate and Reconstitute 40 ˚C under nitrogen stream 200 µL methanol
1. Butyl paraben 2. Doxepin
Chromatogram of Serum Extracts: A) Blank B) Spiked Sample Compound Concentration % Recovery %RSD µg/mL (n=6) 1 Doxepin 0.200 95.8% 1.4% 2 4.00 96.6% 1.9%
0.001 AU
B A
0 4 8 12 MinutesMinutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 79 Enalapril
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Part number: WAT046970 Mobile phase: 10 mM potassium phosphate, pH 2/acetonitrile 75:25 Flow rate: 2 mL/min Injection volume: 2 µL of 1.67 mg/mL Temperature: 80˚ C Detection: UV @ 215 nm
Compounds 1. Maleic Acid 2. Enalapril
1. Maleic Acid 2. Enalapril
Minutes
80 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Endocrine Disruptors in Soil
Oasis® SPE Method for Endocrine Disruptors HPLC Method Conditions for Oasis® HLB Cartridge, 6 cc, 200 mg Part Number WAT106202 ® Column: Symmetry C18, 3.9 x 150 mm, 5 µm Prepare Sample: Part number: WAT046970 adjust to pH 3
Mobile Phase A: 10 mM phosphate pH 6.8 Condition: Mobile Phase B: Methanol 3 mL MTBE* Gradient: Time Profile Rinse: 3 mL methanol Rinse: 3 mL H2O (min) %A %B Load: 06040 up to 500 mL sample 20 0 100 Wash: Flow Rate: 1.0 mL/min 3 mL 5% methanol in H2O Injection volume: 100 µL Elute: Sample: 10 g potting soil extracted with 25 mL 6 mL 10% methanol/MTBEt* acetonitrile; then SPE on Oasis® HLB Detection: PDA (225 nm extracted, 0.04 AUFS) For GC analysis, dry For LC analysis, exchange extract over Na2SO4, to acetonitrile, then then adjust to 1 mL adjust to 1 mL
* methyl t-butyl ether diethyl ether can be used as an alternative to MTBE
1. Benomyl 2. Carbaryl 3. Atrazine 4. Bisphenol A
3
2
4 50 ppb spike level Compounds % Recovery ± % RSD 1. benomyl 62 ± 6 sample 2. carbaryl 91 ± 4 3. atrazine 84 ± 5 blank 4. bisphenol A 78 ± 6 1 Soil samples (5 g) were spiked with the appropriate compounds and extracted with 25 mL of acetonitrile (30 minutes on shaker). A 5 mL aliquot of the acetonitrile extract was diluted to 100 mL with reagent water (MilliQ) and then processed by SPE.
0 5 10
Minutes Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 81 Enkephalins
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column 3.9 x 20 mm, 5 µm Part numbers: Column - WAT046970, Guard - WAT054250 Mobile phase A: 0.1% TFA Mobile phase B: 0.1% TFA in acetonitrile/water 90:10 Gradient: Time Profile (min) %A %B 08020 30 40 60 Flow rate: 1.0 mL/min Injection volume: 5 µL of mixture with 500 µg/mL of each peptide Detection: UV @ 214 nm
USP Tailing Factors 1. 0.99 2. 0.97
Peptides
1: Met enkephalin: Tyr-Gly-Phe-Met
2: Leu enkephalin: Tyr-Gly-Gly-Phe-Leu
Minutes
82 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Etodolac
HPLC Method
™ Column: SymmetryShield RP18, 4.6 x 150 mm, 5 µm Part number: 186000109 Mobile phase: 20 mM phosphate buffer, pH 7.0/acetonitrile 65:35 Flow rate: 1.0 mL/min Injection volume: 5 µL Detection: UV @ 220 nm
USP Tailing Factors 1. 1.16
1. Etodolac
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 83 Flavonoids in Ginkgo
HPLC Method Oasis® HLB method for flavonoids in ginkgo ® Column: Symmetry® C , 4.6 x 250 mm, 5 µm Conditions for Oasis HLB cartridge, 3 cc, 60 mg 18 Part Number WAT094226 Part number: WAT054275 Condition/Equilibrate: Mobile Phase: 0.5% Phosphoric acid/Methanol 50:50 1 mL methanol/1 mL water Flow Rate: 1.5 mL/min Load: Injection volume: 10 µL 3 mL of diluted sample Temperature: 25° C Wash 1: Detection: UV @ 270nm 0.02 AUFS 2 mL 5% methanol/water
Wash 2: 2 ml methanol/ 50mM NH4OAc (30:70) pH 5
Dry Cartridge: air dry for 15 min with vacuum
Elute: 3 ml MTBE/methanol (80:20)
Evaporate and Reconstitute: 1 mL mobile phase
1. Quercetin 2. Kaempferol Sample pre-preparation 1 g sample is refluxed in 50 mL of ethanol: 3M HCl (70:30) for 2.5 hr The cooled sample is adjusted to exactly 100 mL 0.3 mL of the ethanolic extract is diluted 1:10 with water
• Recovery, measured with certified standards at 100 ppm in reagent water, was 82 % for quercitin
1 and > 90 % for the other compounds • All analyses gave results within ± 40 % of the expected values with the exception of the capsule (+ 60%) • The selective SPE extraction and cleanup procedure provided a convenient analysis of ginkgo flavonoids in a complex matrix (Herbal One with 16 herbal ingredients)
2 Compounds % RECOVERY 1. quercetin 82% 2. kaempferol > 90% 3. isorhamnetin > 90% total: 11 mg / tablet
3
10 10 20 MinutesMinutes
84 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Flunitrazepam
HPLC Method
® Column: Symmetry C18,3.9 x 150 mm, 5 µm Part number: WAT046980 Mobile phase: 50 mM potassium phosphate pH 6.0/acetonitrile 60:40 Flow rate: 1.0 mL/min Injection volume: 10 µL of 30 µg/mL flunitrazepam Detection: UV @ 219 nm
USP Tailing Factors 1. 1.2
O N
N O2N F
1. Flunitrazepam
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 85 Flunitrazepam and Related Compounds
HPLC Method Oasis® HLB Extraction Method Oasis® HLB Extraction Plate,30 mg 96-well ™ Column: SymmetryShield RP8, 3.9 x 150 mm, 5 µm Part Number WAT058951 Part number: WAT200655 Condition: Mobile phase: Water/Acetonitrile 70:30 1 mL methanol Flow rate: 1.5 mL/min
Injection volume: 100 µL Equilibrate: Temperature: Ambient 1 mL water Detector: UV @ 220 nm
Load: Compounds: 250 µL 1. 7-Amino Nitrazepam 2. 7-Amino Clonazepam Wash: 3. 7-Amino Flunitrazepam 1 mL, 10% methanol with acetic acid 4. Nitrazepam 5. Clonazepam Elute 1 mL, 40% methanol with ammonium hydroxide 6. Flunitrazepam
Data supplied by J. Vukovik, L. Schofield Waters Ltd., Canada
O N
N O2N F
Flunitrazepam
Compound % Recovery
7-Amino Nitrazepam 118 2 3 4 5 7-Amino Clonazepam 100
6 7-Amino Flunitrazepam 95.9
1 Nitrazepam 93.7
Clonazepam 101
Flunitrazepam 85.9
1 2 3 4 5 6 7 8 9 10 MinutesMinutes
86 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Four Drug Mixture- Warfarin, Dextromethorphan, Triprolidine, and Tetracaine
HPLC Method
™ Column: SymmetryShield RP18,3.9 x 150 mm, 5 µm Part number: 186000108 Mobile phase A: 25 mM Potassium phosphate, pH 7 Mobile phase B: Methanol Gradient: Time Profile (min) %A %B 08515 26 20 80 Flow rate: 1.0 mL/min Injection volume: 10 µL of mixture with 0.3 mg/mL triprolidine, 0.4 mg/mL dextromethorphan, 0.15 mg/mL tetracaine, and 0.05 mg/mL of warfarin Detection: UV @ 280 nm
USP Tailing Factors 1. 1.3 2. 1.6 3. 1.1 4. 1.2
1. Warfarin
2. Dextromethorphan HCL
3. Triprolidine HCL
4. Tetracaine Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 87 Furosemide
HPLC Method
™ Column: SymmetryShield RP18,4.6 x 150 mm, 5 µm Part number: 186000109 Mobile phase: 20 mM phosphate buffer, pH 7.0/acetonitrile 75:25 Flow rate: 1.0 mL/min Injection volume: 5 µL Detection: UV @ 220 nm
USP Tailing Factors 1. 1.30
1. Furosemide
Minutes
88 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Hydrocortisone and Relate Compound
HPLC Method
® Column: Symmetry C18,3.9 x 150 mm, 5 µm Part number: WAT046980 Mobile phase: Acetonitrile/water 35:65 Flow rate: 1.0 mL/min Injection volume: 10 µL of 10 µg/mL hydrocortisone and 30 µg/mL hydrocortisone-21-acetate Detection: UV @ 254 nm
USP Tailing Factors 1. 1.1 2. 1.1
1. Hydrocortisone 2. Hydrocortisone-21-Acetate
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 89 Ibuprofen and Naproxen in Serum
HPLC Method Oasis® HLB Extraction Method Oasis® HLB 1 cc/30 mg Extraction Cartridge ™ Column: SymmetryShield RP8, 3.0 x 150 mm, 5 µm Part Number WAT094425 Guard Column: Sentry™ Guard column, 3.9 x 20 mm, 5 µm
Part Numbers: Column - WAT094243, Guard - WAT200675 Condition 1 mL methanol/1 mL water Mobile phase: 1.2% glacial acetic acid in water, Acetonitrile 50:50 Flow rate: 0.6 mL/min Load Injection: 20 µL of reconstituted porcine serum extract 1 mL spiked porcine serum acidified with Temperature: 25 ˚C 20 µL of phosphoric acid Detection: UV @ 254 nm Wash 1 mL 5% methanol in water Compounds:
1: Naproxen Elute 2: Ibuprofen 1 mL methanol
Evaporate and Reconstitute 40 ˚C under nitrogen stream 200 µL of mobile phase
O CH3
OH H3C
1. Naproxen 2. Ibuprofen
Chromatogram of Serum Extracts: A) Blank B) Spiked Sample
Compound Concentration % Recovery %RSD µg/mL (n=6)
Naproxen 0.100 90.0% 4.0% 0.500 98.7% 1.9% 2.00 99.2% 0.85% Ibuprofen 0.500 86.8% 4.6% B 2.50 95.0% 3.7% A
051015 Minutes
90 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Insulin Chain - QC Batch Test for Symmetry300™ HPLC Columns
HPLC Method
™ Column: Symmetry300 C4 , 3.9 x 150 mm, 5 µm Part number: WAT106154 Mobile phases: A. 25% of 0.05% TFA in Acetonitrile / 75% of 0.05% TFA in Water B. 32% of 0.05% TFA in Acetonitrile/ 68% of 0.05% TFA in Water (Linear Gradient from 100% A to 100% B in 14 Min.) Flow rate: 1.0 mL/min Injection volume: 4 µg, 10 µL Detection: UV @ 220 nm
Compounds: 1. Insulin 2. Desamino 3. Deoxidized
Batch 3 Batch 2 Batch 1
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 91 Insulin- Impurity Isolation, Transfer from Analytical to Prep
HPLC Method
® Columns: A. Symmetry C18, 4.6 x 150 mm, 5 µm ™ B. SymmetryPrep C18, 7.8 x 300 mm, 7 µm ™ C. SymmetryPrep C18, 19 x 150 mm, 7 µm Part numbers: A. WAT045905 B. WAT066235 C. WAT066240 Mobile phases: A. 0.1% TFA in Water B. 0.1% TFA/acetonitrile 26% B to 33% B in 14 minutes adjusted for gradient delay on prep system Flow rates: A. 1.0 mL/min b. 5.76 mL/min c. 17mL/min Detection: UV @ 280 nm Sample Load: Bovine pancreas insulin, 10 mg/mL A. 0.07 mg b. 3 mg c. 8.5mg HPLC Systems: A. analytical system B. and C. prep system with 0.04 in. I.D. tubing
Compounds:
1. Insulin A and B chains with 51 residues, 5733 daltons 2. Impurity
® A. Symmetry C18 , 5 µm, 4.6 mm x 150 mm
™ B. SymmetryPrep C18 , 7 µm, 7.8 mm x 300 mm
™ C. SymmetryPrep C18 , 7 µm, 19 mm x 150 mm
Minutes
92 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Insulin- Isophase Suspension
HPLC Method
® Column: Symmetry C18, 4.6 x 150 mm, 5 µm Part number: WAT045905 Mobile phase A: 0.1% TFA in Water Mobile phase B: Acetonitrile with 0.1% TFA Gradient: Time Profile (min) %A %B 0 100 0 20 40 60 Flow rate: 1.0 mL/min Injection volume: 5 µL of sample with 150 µL of insulin suspension and 300 µL of 0.01N HCL Suspension contains zinc-insulin crystals and protamine sulfate in buffered waters Detection: UV @ 280 nm
USP Tailing Factors 1. 1.1 2. 1.2 3. 1.2
Compounds: 1. Unknown 2. Insulin A and B chains with 51 residues, 5733 daltons 3. Unknown
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 93 Ketoconazole
HPLC Method
™ Column: SymmetryShield RP18,4.6 x 250 mm, 5 µm Part number: 186000112 Mobile phase: 70% diisopropylamine solution/30% ammonium acetate solution Diisopropylamine solution: 2 mL diisopropylamine in 1 L methanol Ammonium acetate solution: 1 g in 200 mL of water Flow rate: 1.5 mL/min Injection volume: 20 µL Detection: UV @ 225 nm
USP Tailing Factors 1. 1.03 2. 1.06
1. Ketoconazole
2. Terconazole
Minutes
94 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Lidocaine HCL
HPLC Method
™ Column: SymmetryShield RP18,4.6 x 250 mm, 5 µm Part number: 186000112 Mobile phase: 50 mL glacial acetic acid in 930 mL of water, pH adjusted to 3.4 with 0.1 N sodium hydroxide/70% buffer/30% acetonitrile Flow rate: 1.5 mL/min Injection volume: 20 µL Detection: UV @ 254 nm
USP Tailing Factors 1. 2.49 2. 0.99
1. Lidocaine HCL
2. Methylparaben
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 95 Lifetime of Symmetry® 3.5 µm Column: 10,000 Injections of Sulfa Drugs
HPLC Method
® Column: Symmetry 3.5µm C18,4.6 x 100 mm Guard Column: Sentry™ Guard column, 3.9 x 20 mm, 5 µm Part numbers: Column - WAT066220, Guard - WAT054225 Mobile phase: Water/methanol/glacial acetic acid 79:20:1 Flow rate: 1.5 mL/min Injection volume: 10 µL of mixture of six sulfa drugs at 10 to 39 µg/mL Detection: UV @ 254 nm 1. Sulfanilamide
O
NH S NH2
N O N
2. Sulfadiazine
H2N
O S
S NH N O
3. Sulfathiazole
NH2
N O
S H C N NH 3 O
4. Sulfamerazine
5. Sulfamethazine
6. Succinylsulfathiazole
End Start
Minutes
96 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Maprotiline HCL
HPLC Method
® Column: Symmetry C18, 3.9 x 150 mm, 5 µm Part number: WAT046980 Mobile phase: 50 mM potassium phosphate pH 3.0/acetonitrile 65:35 Flow rate: 1.0 mL/min Injection volume: 5 µL of 100 µg/mL maprotiline hydrochloride Detection: UV @ 254 nm
USP Tailing Factors 1. 1.4
1. Maprotiline HCL
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 97 Meclizine HCL
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column 3.9 x 20 mm, 5 µm Part numbers: Column - WAT046970, Guard - WAT054250 Mobile phase: 7.4mM sodium 1-heptanesulfonate in water/acetonitrile 58:42 Flow rate: 1.0 mL/min Injection volume: 20 µL of 25 µg /mL sample Detection: UV @ 230 nm
USP Tailing Factors 1. 1.36
1. Meclizine HCL
Minutes
98 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Methadone in Human Urine
HPLC Method Oasis® MCX Extraction Method Oasis® MCX Extraction Cartridge, 3 cc/60 mg ® Part Number 186000254 Column: Symmetry C18, 3.9 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column, 3.9 x 20 mm, 5 µm No Conditioning Part numbers: Column - WAT046980, Guard - WAT054225 Mobile phase: 0.1% TFA in water/Methanol 60:40 Load Flow rate: 1 mL/min 3 mL acidified spiked human urine Injection volume: 100 µL urine extract Wash 1 Temperature: 30˚ C 2 mL 0.1M hydrochloric acid Detection: UV @ 210 nm Wash 2 2 mL methanol Compounds: 1. EDDP (0.2 µg/mL) Optional Wash 3 2 mL of 5% ammonium hydroxide 2. Estazolam (I.S.) (0.2 µg/mL) with 60% methanol 3. Methadone (0.2 µg/mL) Elute 2 mL 5% ammonium hydroxide with 95% methanol
Each elution diluted 1:1 with water for HPLC analysis
N N N CH3 CH O 3 CH N 3 N + N Cl CH3 CH3 CH3
CH3 1. EDDP (Methadone Metabolite) 2. Estazolam 3. Methadone
Chromatogram of Human Urine: A) Spiked Sample, B) Blank
3 %Recovery (%RSD) Compound n=3 n=9 1 (1 Subject) (3 Subject) (3 SPE Washes) (2 SPE Washes)
2 Methadone (0.5 µg/mL) 95.2 (1.0) 97.4 (3.0) Methadone (0.1 µg/mL) 98.0 (4.8) 114.7 (8.2) EDDP (0.2 µg/mL) 93.3 (1.0) 92.9 (2.4) 0.01 AU EDDP (0.4 µg/mL) 98.4 (2.9) 100.5 (5.8) Estazolam (IS) 94.4 (3.3) 91.2 (91.2)
A B
0 5 10 15
MinutesMinutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 99 Methylphenidate HCL
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column 3.9 x 20 mm, 5 µm Part numbers: Column - WAT046970, Guard - WAT054250 Mobile phase: 20 mM potassium phosphate, pH 2.18/methanol 80:20 Flow rate: 1.0 mL/min Injection volume: 15 µL of 200 µg/mL Detection: UV @ 254 nm
USP Tailing Factors 1. 1.5
1. Methylphenidate HCL
Minutes
100 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Metoprolol Tartrate and Oxprenolol
HPLC Method
™ Column: SymmetryShield RP18, 4.6 x 250 mm, 5 µm Part number: 186000112 Mobile phase: 1.92 g of 1-pentansulfonic acid sodium salt monohydrate, 0.27 g of sodium acetate trihydrate and 1.14 mL glacial acetic acid in 940 mL of water; 54% methanol/46% buffer Flow rate: 1.0 mL/min Injection volume: 30 µL Detection: UV @ 254 nm
USP Tailing Factors 1. 1.29 2. 1.98
1. Metoprolol tartrate
2. Oxprenolol
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 101 ™ Metronidazole (SymmetryShield RP18)
HPLC Method
™ Column: SymmetryShield RP18, 4.6 x 150 mm, 5 µm Part number: 186000109 Mobile phase: 20 mM phosphate buffer, pH 7.0/acetonitrile 95:5 Flow rate: 1.0 mL/min Injection volume: 5 µL Detection: UV @ 254 nm
USP Tailing Factors 1. 1.03
1. Metronidazole
Minutes
102 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Metronidazole (Symmetry C18)
HPLC Method
® Column: Symmetry C18, 3.9 x 150 mm, 5 µm Part number: WAT046980 Mobile phase: Water/Methanol 90:10 Flow rate: 1.0 mL/min Injection volume: 10 µL of 100 µg/mL metronidazole Detection: UV @ 254 nm
USP Tailing Factors: 1. 1.2
1. Metronidazole
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 103 Morphine and Its Glucuronide Metabolites in Serum
HPLC Method Oasis® HLB Extraction Method Oasis® HLB 1 cc/30 mg Extraction Cartridge ™ Column: SymmetryShield RP8, 3.9 x 150 mm, 5 µm Part Number WAT094225 Part number: WAT200655 Condition Mobile phase: 20 mM potassium phosphate, pH 6.4 1 mL methanol Flow rate: 1.0 mL/min Injection volume: 100 µL of porcine serum extract Equilibrate Detection: Fluorescence; ex 280 nm, em 355 nm 1 mL water
Load Compounds: 1 mL spiked porcine serum 1: Morphine-D3-glucuronide 2: Morphine-D6-glucuronide Wash 3: Morphine 1 mL water
Elute 0.5 mL 3% triethylamine
No Evaporation Sample injected directly
HO
COOH HO O O O OH H HO NCH3 OH COOH O H O H O O NCH3 OH NCH3 HO HO OH HO 1. Morphine-D3-glucuronide 2. Morphine-D6-glucuronide 3. Morphine
Chromatogram of Serum Extracts: A) Blank B) Spiked Sample
Compound Concentration % Recovery %RSD 6 3 µg/mL (n=6)
Morphine-D3-glucuronide 0.48 90.7 2.0 0.097 100 3.1 1 Morphine-D6-glucuronide 2.4 92.2 2.8
2 0.49 93.1 2.5 Morphine 3.6 102 3.6 mV 0.73 102 3.2
B A
05 10 15
MinutesMinutes
104 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Nadolol
HPLC Method
™ Column: SymmetryShield RP18, 4.6 x 250 mm, 5 µm Part number: 186000112 Mobile phase: Methanol/water 35:65, 2.93 g of sodium chloride, 1.0 mL of 0.1 N hydrochloric acid Flow rate: 1.0 mL/min Injection volume: 20 µL Detection: UV @ 220 nm
USP Tailing Factors 1. 1.19
1. Nadolol
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 105 Naltrexone
HPLC Method
™ Column: SymmetryShield RP8, 3.9 x 150 mm, 5 µm Part number: WAT200655 Mobile phase: 100 mM Ammonium acetate, pH 5.0/acetonitrile 88:12 Flow rate: 1.0 mL/min Injection volume: 35 µL (500 µL eluate) Detection: UV @ 281 nm
USP Tailing Factors 1. 1.05 2. 1.04
1. Naloxone (I.S.)
HO
O OH N O
2. Naltrexone
Minutes
106 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Naltrexone in Plasma
HPLC Method Oasis® HLB Extraction Method Oasis® HLB Extraction Plate, 30 mg/96-well ™ Column: SymmetryShield RP8, 3.9 x 150 mm, 5 µm Part Number WAT058951 Part number: WAT200655 Mobile phase: 100 mM Ammonium acetate pH 5/acetonitrile 88:12 Condition 1 mL methanol/1 mL water Flow rate: 1.0 mL/min
Injection volume: 1 mL spiked plasma with naloxone (I.S.) Load Temperature: 8˚ C 1 mL spiked plasma with naloxone (I.S.) Detection: UV @ 281 nm
Wash Compounds: 1) 1 mL 5% methanol containing 2% ammonium hydroxide 1. Naloxone (I.S.) 2) 1 mL 20% methanol containing 2. Naltrexone 2% ammonium hydroxide
Elute 0.5 mL of 25% methanol containing 2% acetic acid
Evaporate and Reconstitute Not required
HO
O OH N O
1. Naloxone (I.S.) 2. Naltrexone
Chromatogram of Plasma Extracts: A) Blank B) Spiked Sample
1
2
0.001 AU
Compound Concentration % Recovery %RSD µg/mL (n=6) B A Naltrexone 3.3 108% 4.2%
02 4 6 8 10
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 107 Naltrexone in Plasma - LC/MS
HPLC Method Oasis® HLB Extraction Method Oasis® HLB Extraction Plate, 30 mg/96-well ® Part Number WAT058951 Column: Symmetry C8, 2.1 x 30 mm, 5 µm
Part number: WAT058977 Condition 1 mL of methanol/1mL water Mobile phase: 10 mM NH4OH, pH 5/Acetonitrile 88:12 Flow rate: 200 µL/min Loading Injection volume: 50 µL plasma extract 1 mL of spiked plasma ™ MS: Micromass Quattro II Wash 1 Ion Source Temp: 120˚ C 1 mL of 5% methanol/ 2% ammonium hydroxide CID: 1.8e-3 mBar, 20 eV Desolvation Temp: 400 ˚C Wash 2 1 mL of 20% methanol/ Nebulizer: 40 L/hr 2% ammonium hydroxide Drying gas: 400 L/hr Elution Cone volt: 56 V 0.5 mL 25% methanol/ 1% acetic acid
Dilution 0.5 mL water CID mass spectra
100 HO 324 A Analyte: -H O 2 Naltrexone O OH 324 N O Conc Average % Std. Dev (RSD%) (rel. error) ng/mL n=8 0 0 310 0.5 0.6 0.09 16 15 100 B HO 1 0.9 0.06 6 -14 Int. Std.: -H2O Naloxone O OH 5 5.1 0.2 4 3 N 328 10 10.1 0.4 4 1 O Relative Abundance (%) 0 20 19.7 0.8 4 -2 0 100 200 300 400 50 49.1 3.9 8 -2 Mass/Charge (m/z) 100 101.1 3.7 4 1 Naltrexone m/z 342 > 324 Naloxone m/z 328 > 310
HPLC-MS/MS (MRM Analysis at 0.5 ng/mL and 100 ng/mL 5.35 0.6
1.38 100100 1.38 0.5 ng/mL 342.1>324.0 % A 0
0.38 0 10 0.12 0.58 1.12 1.80 779 0
0 1.19 100 Response 100 1.19 328.0>310.0 % B 2.14e4 0 Time 0 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0 1.34 100 1.34 100 100 ng/mL 342.1>324.0 0.0 50.0 100.0
% C 8.90e4 Conc. (ng/mL)
0
0 1.17 100 Coefficient of Determination: 0.996457 100 1.17 328.0>310.0 % D Calibration Curve: 0.0508208* x + 0.00306776 2.42e4 0 Time Response type: Internal Std (20 ng/mL Naloxone), 0 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.5 1.0 1.5 2.0 Area * ( IS Conc. / IS Area) Curve type: Linear, Origin: Exclude, Weighting: 1x, Axis trans: None Time (min)
108 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Naltrexone in Serum
HPLC Method Oasis® HLB Extraction Method Oasis® HLB 1 cc/30 mg Extraction Cartridge
™ Part Number WAT094225 Column: SymmetryShield RP8, 3.0 x 150 mm, 5 µm ™ Guard Column: Sentry guard column, 3.9 x 20 mm, 5 µm Condition Part numbers: Column - WAT094243, Guard - WAT200675 1 mL methanol/1 mL water Mobile phase: 20 mM ammonium acetate, pH 5/acetonitrile, 90:10 Load Flow rate: 0.6 mL/min 1 mL spiked porcine serum with 0.2 µg naloxone (I.S.) Injection volume: 20 µL of reconstituted porcine serum extract
Temperature: 25˚ C Wash Detection: UV @ 215 nm 1 mL 5% methanol in water
Elute Compounds: 1 mL methanol 1: Naloxone (I.S.) Evaporate and Reconstitute 2: Naltrexone 40 ˚C under nitrogen stream 200 µL mobile phase
HO
O OH N O
1. Naloxone (I.S.) 2. Naltrexone
Chromatogram of Serum Extracts: A) Blank B) Spiked Sample
Compound Concentration % Recovery %RSD µg/mL (n=6)
Naltrexone 0.200 98% 3.2% 1 1.00 100% 3.5%
2
B
0.05 AU A
0 5 10 15 Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 109 ® Naproxen (Symmetry C8)
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column 3.9 mm x 20 mm, 5 µm Part numbers: Column - WAT046970, Guard - WAT054250 Mobile phase: Acetonitrile/water/glacial acetic acid 50:49:1 Flow rate: 1.0 mL/min Injection volume: 5 µL of 100 µg/mL sample Detection: UV @ 254 nm
USP Tailing Factors 1. 1.15
1. Naproxen
110 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. ™ Naproxen (SymmetryShield RP18)
HPLC Method
™ Column: SymmetryShield RP18, 4.6 x 250 mm, 5 µm Part number: 186000112 Mobile phase: Acetonitrile/water 46:54, 2.0 mL of glacial acetic acid in 1 L of mobile phase Flow rate: 1.0 mL/min Injection volume: 20 µL Detection: UV @ 254 nm
USP Tailing Factors 1. 1.09 2. 1.13
1. Naproxen
O
2. Butyrophenone
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 111 Nicergoline
HPLC Method
® Column: Symmetry C18, 3.9 x 150 mm, 5 µm Part number: WAT046980 Mobile phase: Acetonitrile/100 mM sodium acetate, pH 5.0 40:60 Flow rate: 1.0 mL/min Injection volume: 10 µL of 30 µg/mL nicergoline Detection: UV @ 227 nm
USP Tailing Factor 1. 1.2
1. Nicergoline
Minutes
112 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Nifedipine
HPLC Method
™ Column: SymmetryShield RP18, 4.6 x 150 mm, 5 µm Part number: 186000109 Mobile phase: 20 mM phosphate buffer, pH 7.0/acetonitrile 40:60 Flow rate: 1.0 mL/min Injection volume: 5 µL Detection: UV @ 240 nm
USP Tailing Factors 1. 1.03
1. Nifedipine
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 113 Oxycodone in Serum
HPLC Method Oasis® HLB Extraction Method Oasis® HLB 1 cc/30mg Extraction Cartridge ™ Part Number WAT094225 Column: SymmetryShield RP8, 3 x 150 mm, 5 µm ™ Guard Column: Sentry RP8, guard column, 3.9 x 20 mm, 5 µm Condition: Part Numbers: Column - WAT094243, Guard - WAT200675 1 mL methanol/1 mL water Mobile phase: 20 mM ammonium acetate, pH 5/acetonitrile, 90:10
Flow rate: 0.6 mL/min Load: Injection volume: 20 µL of reconstituted porcine serum extract 1 mL spiked porcine serum with 0.2 µg naloxone (I.S.) Temperature: 25˚ C Detection: UV @ 215 nm Wash: 1 mL 5% methanol in water Compounds: 1: Oxycodone 2: Naltrexone (I.S.) Elute: 1 mL methanol
Evaporate and Reconstitute: 40˚ C under nitrogen stream, 200 µL mobile phase
H3CO HO
O OH O OH NCH3 N O O 1. Oxycodone 2. Naltrexone (I.S.)
Chromatogram of Serum Extracts: A) Blank B) Spiked Sample
Compound Concentration % Recovery %RSD µg/mL (n=6)
Oxycodone 0.200 96.0% 6.4% 1.00 97.9% 1.0%
1
2 0.05 AU
B A
0 5 10 15 MinutesMinutes
114 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Oxytocin and Angiotensins in Serum
HPLC Method Oasis® HLB Extraction Method Oasis® HLB 1 cc/30 mg Extraction Cartridge ™ Column: SymmetryShield RP8, 4.6 x 100 mm, 3.5 µm Part Number WAT094225 Guard Column: Sentry™ guard column 3.9 x 20 mm, 3.5 µm Condition Part numbers: Column - WAT094226, Guard - 186000704 1 mL methanol/1 mL water Mobile phase A: 0.1% TFA in water
Mobile phase B: Acetonitrile/water 90:10 with 0.1% TFA Load 15 to 60% B in 22 minutes 1 mL spiked porcine serum with 20 µL of phosphoric acid Gradient: Time Profile (min) %A %B Wash 08515 1 mL 10% acetonitrile in 0.1% TFA 22 40 60 Flow rate: 1.4 mL/min Elute 1 mL acetonitrile/water 80:20 Injection volume: 30 µL of reconstituted porcine extract (with or without 0.1% TFA-no impact) Temperature: 30˚ C Detection: UV @ 214 nm Evaporate and Reconstitute 40 ˚C under nitrogen stream 1 mL 0.1% aqueous TFA (for greater Compounds: sensitivity use less volume 1. Oxytocin for reconstituting sample) 2. Angiotensin II 3. Angiotensin I (I.S.)
1. Oxytocin 2. Angiotensin II 3. Angiotensin I
Chromatogram of Serum Extracts: A) Blank B) Spiked Sample
3 2 B.
1 A.
0.05
Compound Concentration % Recovery %RSD µg/mL (n=6)
Oxytocin 5.0 103.7% 1.9% Angiotensin I 5.0 97.8% 2.0% Angiotensin II 5.0 99.2% 4.3%
46MinutesMinutes 8
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 115 Paclitaxel (Taxol)
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Part number: WAT046980 Mobile phase: 20 mM ammonium acetate, pH 5.0/acetonitrile/methanol 50:40:10 Flow rate: 1 mL/min Injection volume: 5 µL of 100 µg/mL Detection: UV @ 227 nm
USP Tailing Factors 1. 1.0
1. Paclitaxel (Taxol)
Minutes
116 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Paclitaxel (Taxol)- Resolution of Impurities
HPLC Method
® Column: Symmetry C18, 4.6 x 100 mm, 3.5 µm Part number: WAT066220 Mobile phase: Water/acetonitrile/methanol 57:34:9 Flow rate: 1.4 mL/min Injection volume: 25 µL of paclitaxel, 1 mg/mL in methanol Detection: UV @ 230 nm
1. Paclitaxel (Taxol)
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 117 Papaverine HCL
HPLC Method
® Column: Symmetry C18,3.9 x 150 mm, 5 µm Part number: WAT046980 Mobile phase: 10 mM sodium phosphate pH 3.0, 2.88 g/L sodium lauryl sulfate/acetonitrile 50:50 Flow rate: 1.0 mL/min Injection volume: 10 µL of 20 µg/mL papaverine hydrochloride Detection: UV @ 254 nm
USP Tailing Factor 1. 1.1
1. Papaverine HCL
Minutes
118 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Paracetamol
HPLC Method
™ Column: SymmetryShield RP18,4.6 x 150 mm, 5 µm Part number: 186000109 Mobile phase: 20 mM phosphate buffer, pH 7.0/acetonitrile 85:15 Flow rate: 1.0 mL/min Injection volume: 5 µL Detection: UV @ 254 nm
USP Tailing Factor 1. 1.06
1. Paracetamol
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 119 Paraquat and Diquat in Tap Water
HPLC Method Oasis® MCX Method for Quaternary Amines in Drinking Water Conditions for Oasis® MCX Cartridge, 3 cc, 60 mg Column: Symmetry® C , 3.9 x 150 mm, 5 µm 18 Part Number 186000254 Part number: WAT046980
Mobile Phase: 25 mM Octanesulfonate, pH 3.0/methanol 45:55 Condition: 3 mL methanol Flow Rate: 0.75 mL/min Rinse with 3 mL H2O Injection volume: 80 µL Sample: 200 mL spiked tap water processed Load: 250 mL sample on Oasis® MCX cartridge Detection: PDA, 257 nm for Paraquat, 308 nm for Diquat Wash: 3 mL 50% methanol/ H2O
Elute: 2 mL of 1 M NH4CI in 50% methanol/ H2O
For LC analysis dilute the eluent to 5 mL with 50 mM sodium octanesulfonate
+ + N+ NCHN CH3 3 N +
1. Paraquat 2. Diquat
Compounds 2 mg/L Spike Level % Recovery, n=5 0.5 µg/L 2.0 µg/L 1 1. Paraquat 111 + 7110+5 2. Diquat 91 + 4 96 + 4 2
257 nm PDA (0.08 AUFS)
308 nm
2 4 6 Minutes
120 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Peptides- Alberta Peptide Mixture
HPLC Method
® Column: Symmetry C18,3.9 x 150 mm, 5 µm Part number: WAT046980 Mobile phase A: 0.1% TFA in water Mobile phase B: 0.1% TFA in acetonitrile Gradient: Time Profile (min) %A %B 09010 30 60 40 35 40 60 Flow rate: 0.8 mL/min Injection volume: 9 µL of peptide mixture; lyophilized sample dissolved in 1 mL mobile phase Temperature: 35˚ C Detection: UV @ 214 nm
USP Tailing Factors 1. 1.3 2. 1.2 3. 1.2 4. 1.2 5. 1.3 Peptides: Ac-Arg-Gly-x-x-Gly-Leu-Gly-Leu-Gly-Lys-amide where x-x= S1 Ala=Gly with free N alpha amino group S2 Gly-Gly S3 Ala-Gly S4 Val-Gly S5 Val-Val
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 121 Pharmaceutical Test Mix - 2.1 x 20 mm Intelligent Speed™ Separation
HPLC Method
® ™ Columns: Symmetry C18,2.1 x 20 mm, 3.5 µm IS ™ ™ SymmetryShield RP18,2.1 x 20 mm, 3.5 µm IS Part numbers: Symmetry - 186002066 O OH SymmetryShield - 186002068 N NH O Mobile phase A: 0.1% HCOOH in Water Br HO OH N N NH2 Mobile phase B: 0.1% HCOOH in ACN HO O H OH
O Gradient: H Time Profile H H F NH H H H3C O (min) %A %B OH H 0 100 0 1. 8-Bromoguanosine 2. Acetanilide 3. Triamcinolone 40 100 OH
Flow rate: 0.6 mL/min O O HO OH Injection volume: 5 µL OH H Temperature: 30˚ C H HH Detection: UV @ 254 nm H H O O 5. 2-Amino-7-chlro-5-oxo-5H-[1]benzopyrano 4. Hydrocortisone [2,3-b]pyridine-3 carbonitrile 6. 6a-Methyl-17a-hydroxyprogesterone
NH2
Br
7. 3-Aminofluorathene 8. 2-Bromofluorene 9. Perylene 10. Naptho(2,3-a)pyrene
4 ® 2 Symmetry C18, 3.5µm 1 t0 = 0.20 min 3 5 6 8 7 9 Max PSI = 1224 10
0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 Compounds: 1. 8-Bromoguanosine MiMinutesnutes 2. Acetanilide 3. Triamcinolone 4 ™ 2 SymmetryShield RP18, 3.5µm 4. Hydrocortisone 5. 2-Amino-7-chloro-5-oxo-5H-[1] benzopyrano[2,3-b]pyridine-3-carbonitrile 1 8 6 6. 6λMethyl-17λ-hydroxyprogesterone 7. 3-Aminofluoranthene 379 5 10 8. 2-Bromofluorene
t0 = 0.20 min 9. Perylene Max PSI = 1424 10. Naphtho(2,3-a)pyrene
0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00
MiMinutesnutes
122 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Pharmaceutical Test Mix - 4.6 x 20 mm Intelligent Speed™ Separation
HPLC Method
® ™ Columns: Symmetry C18,4.6 x 20 mm, 3.5 µm IS ™ ™ SymmetryShield RP18,4.6 x 20 mm, 3.5 µm IS O OH
N Part numbers: Symmetry - 186002090 NH O Br SymmetryShield - 186002092 HO OH N N NH 2 H OH Mobile phase A: 0.1% HCOOH in Water HO O O H H H F Mobile phase B: 0.1% HCOOH in ACN NH H H H3C O Gradient: Time Profile OH H 1. 8-Bromoguanosine 2. Acetanilide 3. Triamcinolone (min) %A %B OH 0 100 0 O 40 100 O HO OH OH Flow rate: 3.0 mL/min H H
Injection volume: 10 µL HH H H O Temperature: 30˚ C O Detection: UV @ 254 nm 5. 2-Amino-7-chlro-5-oxo-5H-[1]benzopyrano 4. Hydrocortisone [2,3-b]pyridine-3 carbonitrile 6. 6a-Methyl-17a-hydroxyprogesterone
NH2
Br
7. 3-Aminofluorathene 8. 2-Bromofluorene 9. Perylene 10. Naptho(2,3-a)pyrene
® 2 Symmetry C18, 3.5µm 4 t0 = 0.14 min 1 Max PSI = 1169 6 8 3 5 9 7 10
0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 4.50 MiMinutesnutes
Compounds: SymmetryShield™ RP , 3.5µm 18 1. 8-Bromoguanosine 2 2. Acetanilide 4 3. Triamcinolone 4. Hydrocortisone 5. 2-Amino-7-chloro-5-oxo-5H-[1] benzopyrano[2,3-b]pyridine-3-carbonitrile 1 68 6. 6λMethyl-17λ-hydroxyprogesterone t0 = 0.17 min 9 7. 3-Aminofluoranthene Max PSI = 1122 7 3 5 10 8. 2-Bromofluorene 9. Perylene 10. Naphtho(2,3-a)pyrene
0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 4.50
MiMinutesMinutesnutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 123 Phencyclidine in Human Urine
HPLC Method Oasis® MCX Extraction Method Oasis® MCX Extraction Plate, 30 mg/96-well ™ Column: SymmetryShield RP18, 3.9 x 150 mm, 5 µm Part Number 186000248 ™ Guard Column: Sentry Guard Column RP18, 3.9 x 20 mm, 5 µm Load Part numbers: Column - 186000108, Guard - 186000107 1 mL x 4 of acidified spiked human Mobile phase: 50 mM Phosphate buffer, pH 7/Acetonitrile 70:30 urine (4 mL Total Sample) Flow rate: 1 mL/min Wash 1 Injection volume: 20 µL urine extract 1 mL 0.1N hydrochloric acid Temperature: 30˚ C Detection: UV @ 210 nm (0.01 AUFS) Wash 2 1 mL methanol Compounds: 1. Phencyclidine Elute 2. Ketamine HCI 1 mL 5% ammonium hydroxide with 95% methanol
CI O
N NH
CH3 1. Phencyclidine (PCP) 2. Ketamine (I.S.)
Chromatogram of A) Spiked Urine, B) Blank Urine
Compound % Recovery (n=6) %RSD (n=6) 0.3 µg/mL 1.5 µg/mL 2 Phencyclidine (PCP) 101.7 (2.3) 100.2 (0.8) 1 Ketamine (I.S.) 86.5 (1.0) 0.01 AUFS
A
B
0 7 14
MinutesMinutes
124 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Phenolics in Echinacea
HPLC Method Oasis® MAX method for phenolics in echinacea Conditions for Oasis® MAX Cartridge, 3 cc, 60 mg Part Number 186000367 ® Column: Symmetry C18, 4.6 x 250 mm, 5 µm Condition/Equilibrate: Part number: WAT054275 1 mL methanol/1 mL water Mobile Phase A: 0.1% phosphoric acid Load: Mobile Phase B: Acetonitrile 3 mL of diluted sample Gradient: Time Profile Wash 1: (min) %A %B 2 mL of 50 mM sodium acetate 09010 13 78 22 Wash 2: 2 mL of methanol 40 60 40 Flow Rate: 1.5 mL/min Dry Cartridge: air dry for 15 min with vacuum Injection volume: 10 µL Temperature: 35° C Elute: 3 mL MTBE/methanol/TFA (49:49:2) Detection: UV @ 330 nm Evaporate and Reconstitute: 1 mL mobile phase
Herbal tea extract Herbal tea extract after SPE cleanup before SPE cleanup using Oasis® MAX
Sample pre-preparation 100 mg sample is extracted with 25 mL of ethanol:water (70:30) 1 mL of the ethanolic extract is diluted 1:3 with water (~ pH 7)
• Recovery, measured with certified standards at 100 ppm in reagent water, 3 was greater than 85 % for all compounds • All analyses gave results within ± 35 % of the expected values with the exception of the liquid supplement (see goldenseal analysis) • The selective SPE extraction and cleanup procedure provided a convenient analysis of echinacea phenolics in complex matrix such as in herbal tea
1. cafteric acid 2. chlorogenic acid 3. cichoric acid 1 total: 5 mg / teabag
Tea bag extract 2
0 10 20 MinutesMinutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 125 Prednisone
HPLC Method
™ Column: SymmetryShield RP18, 4.6 x 150 mm, 5 µm Part number: 18600109 Mobile phase: 20 mM Phosphate buffer, pH 7/Acetonitrile 65:35 Flow rate: 1.0 mL/min Injection volume: 5 µL Detection: UV @ 254 nm
USP Tailing Factor 1. 1.02
1. Prednisone
Minutes
126 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Procainamide in Serum
HPLC Method Oasis® HLB Extraction Method Oasis® HLB 1 cc/30 mg Extraction Cartridge ™ Part Number WAT094225 Column: SymmetryShield RP8, 3.9 x 150 mm, 5 µm ™ Guard Column: Sentry guard column, 3.9 x 20 mm, 5 µm Condition Part numbers: Column - WAT200655, Guard - WAT200675 1 mL methanol/1 mL water Mobile phase: 20 mM potassium phosphate, pH 3.0/methanol 97:3 Load Flow rate: 1.0 mL/min 1 mL spiked porcine serum Injection volume: 50 µL of reconstituted porcine serum extract
Temperature: 30˚ C Wash Detection: UV @ 220 nm 1 mL 5% methanol in water
Compounds: Elute 1 mL methanol 1: Procainamide
2: Sulfanilamide (I.S.) Evaporate and Reconstitute 40 ˚C under nitrogen stream 200 µL of 50 µg/mL sulfanilamide (I.S.) in water
O CH2 CH3 N H N N 2 H CH2 CH3
1. Procainamide 2. Sulfanilamide
Chromatogram of Serum Extracts: A) Blank B) Spiked Sample
Compound Concentration % Recovery %RSD µg/mL (n=6)
Procainamide 0.100 93.8% 1.8% 0.500 98.1% 2.1%
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 127 Procainamides at pH 3.0
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column 3.9 x 20 mm, 5 µm Part numbers: Column - WAT046970, Guard - WAT054250 Mobile phase: 50 mM potassium phosphate, pH 3.0/methanol 85:15 Flow rate: 1.0 mL/min Injection volume: 10 µL of 40 µg/mL sample Detection: UV @ 254 nm
USP Tailing Factors 1. 1.2 2. 1.0 3. 1.0
1. Procainamide
2. N-Acetylprocainamide
3. N-Propionylprocainamide
Minutes
128 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Procainamides at pH 6.0
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Part number: WAT046970 Mobile phase: 20 mM potassium phosphate, pH 6.0/acetonirtrile 90:10 Flow rate: 1.0 mL/min Injection volume: 10 µL of 40 µg/mL each compound Detection: UV @ 254 nm
USP Tailing Factors 1. 1.4 2. 1.4 3. 1.4
1. Procainamide
2. N-Acetylprocainamide
3. N-Propionylprocainamide
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 129 Prochlorperazine - Isolation of Degradation Products, Transfer from Analytical to Prep
HPLC Method
® Columns: A. Symmetry C18, 3.9 x 150 mm, 5 µm ™ B. SymmetryPrep C18, 7.8 x 150 mm, 7 µm Part numbers: A. WAT046980, B. WAT066288 Mobile phase A: 0.1% TFA in Water Mobile phase B: Acetonitrile Gradient: Time Profile (min) %A %B 09010 50 40 60 Flow rate: A. 0.7 mL/min B. 2.8 mL/min Injection volume: Prochlorperazine edisylate A. 0.8 mg B. 3.2mg Detection: UV @ 280 nm
1. Prochlorperazine Edisylate
® 1. Symmetry C18 , 5 µm, 3.9 mm x 150 mm
™ 2. SymmetryPrep C18 , 7 µm, 7.8 mm x 150 mm
Minutes
130 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Profens (Gradient)- 4.6x 20mm Intelligent Speed™ Separation
HPLC Method
® ™ O CH Columns: Symmetry C18,4.6 x 20 mm, 3.5 µm IS 3 ™ ™ O SymmetryShield RP18,4.6 x 20 mm, 3.5 µm IS Part numbers: Symmetry - 186002090 OH SymmetryShield - 186002092 Mobile phase A: 0.1% HCOOH in Water Mobile phase B: 0.1% HCOOH in ACN 1. Ketoprofen Gradient: Time Profile (min) %A %B
06535 O 26040 Flow rate: 3.0 mL/min O OH
Injection volume: 10 µL CH3 Temperature: 30˚ C 2. Fenoprofen Detection: UV @ 220 nm O OH Compounds:
1. Ketoprofen CH3 2. Fenoprofen 3. Flurbiprofen F 4. Ibuprofen 3. Flurbiprofen
CH3 2 ® Symmetry C18, 3.5µm O CH3
OH H3C 1 4 3 4. Ibuprofen
t0 = 0.15 min Max PSI = 1111
0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 2.00
Minutes
™ SymmetryShield RP18, 3.5µm 2
1 3 4 t0 = 0.19 min Max PSI = 1090
0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 2.00
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 131 Profens (Isocratic) - 4.6 x 20 mm Intelligent Speed Separation
HPLC Method
O CH3 Columns: Symmetry® C ,4.6 x 20 mm, 3.5 µm IS™ 18 O ™ ™ SymmetryShield RP18,4.6 x 20 mm, 3.5 µm IS Part numbers: Symmetry - 186002090 OH SymmetryShield - 186002092 1. Ketoprofen Mobile phase A: 0.1% HCOOH in Water Mobile phase B: 0.1% HCOOH in ACN Isocratic: 65% A, 35% B Flow rate: 3.0 mL/min O Injection volume: 10 µL O OH Temperature: 30˚ C CH Detection: UV @ 220 nm 3 2. Fenoprofen
Compounds: O OH 1. Ketoprofen 2. Fenoprofen CH 3. Flurbiprofen 3 4. Ibuprofen
F
3. Flurbiprofen
CH3
O 2 CH3
OH H3C ® 1 Symmetry C18, 3.5µm
4. Ibuprofen t0 = 0.15 min 3 Max PSI = 1111 4
0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00
Minutes
2
™ SymmetryShield RP18, 3.5µm 1 t0 = 0.18 min Max PSI = 1082 3 4
0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 Minutes
132 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Promethazine- Impurities Profile
HPLC Method
™ Column: SymmetryShield RP18, 3.0 x 150 mm, 5 µm Part number: 186000692 Mobile phase A: 20 mM potassium phosphate, pH 7.0 Mobile phase B: Acetonitrile Gradient: Time Profile (min) %A %B 0955 30 20 80 Flow rate: 1.0 mL/min Injection volume: 10 µL of 0.5 mg/mL Detection: UV @ 254 nm
1. Promethazine HCL
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 133 Propranolol in Human Urine
HPLC Method Oasis® MCX Extraction Method Oasis® MCX Extraction Cartridge, 3 cc/60 mg ™ Part Number 186000254 Column: SymmetryShield RP18, 3.9 x 150 mm, 5 µm ™ Guard Column: SymmetryShield RP18, 3.9 x 20 mm, 5 µm Load Part numbers: Column - 186000108, Guard - 186000107 3 mL acidified spiked human urine Mobile phase: 0.1% TFA in water/Acetonitrile 80:20 No Conditioning Flow rate: 1 mL/min Injection volume: 50 µL Wash 1 Temperature: 30˚ C 2 mL 0.1M hydrochloric acid Detection: UV @ 275 nm Wash 2 2 mL of 100% methanol Compounds: Wash 3 1. Metoprolol 2 mL of 50% methanol with 2. Oxprenolol (I.S.) 5% ammonium hydroxide 3. Propranolol Elute 2 mL 95% methanol with 5% ammonium hydroxide
Neutralize each elution with 100 µL of acetic acid. Evaporate une N2 at 40 ˚C and reconstitute with 300 µL of water
CH OH 3 H H NCH O 3 O N CH3 O N CH3 H OH CH CH2 CH 3 O 3 H3CO
1. Metoprolol 2. Oxprenolol (I.S.) 3. Propranolol
Chromatogram of A) Spiked Urine, B) Blank Urine
3 2 Compound %Recovery (%RSD) 0.08 µg/mL 0.4 µg/mL 1 Propranolol (n=3) 105.8 (2.7) 98.5 (0.7) Metoprolol (n=3) 101.0 (3.4) 99.6 (0.4) Propranolol Interday (n=6) 99.0 (0.9)
0.0080 AUFS Propranolol Interperson (n=9) 100.4 (6.4) Metoprolol Interday (n=6) 100.3 (0.9) Metoprolol Interperson (n=9) 97.3 (2.6)
B Oxprenolol (I.S.) 91.1 (3.2) A
0 481216 MinutesMinutes
134 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Propranolol in Serum
Oasis® HLB Extraction Method HPLC Method Oasis® HLB 1 cc/30mg Extraction Cartridge ™ Column: SymmetryShield RP8, 3.9 x 150 mm, 5 µm Part Number WAT094225 Guard Column: Sentry™ guard column, 3.9 x 20 mm, 5 µm Condition Part numbers: Column - WAT200655, Guard - WAT200675 1 mL methanol/1 mL water Mobile phase: 20 mM potassium phosphate, pH 7/methanol 38:62 Flow rate: 1.0 mL/min Load Injection volume: 20 µL of reconstituted porcine serum extract 1 mL spiked porcine serum Temperature: 30˚ C Wash Detection: UV @ 254 nm 1 mL 5% methanol in water
Compounds: Elute 1: Propranolol 1 mL methanol with 5 µg butyl paraben 2: Butyl paraben (I.S.)
Evaporate and Reconstitute 40 ˚C under nitrogen stream 200 µL methanol
OH N O H
1. Propranolol 2. Butyl paraben (I.S.)
Chromatogram of Serum Extracts: A) Blank B) Spiked Sample
2
1
0.002 AU
B Compound Concentration % Recovery %RSD µg/mL (n=6) A Propranolol 0.800 85.9% 2.1% 4.00 96.4% 2.4%
0 4 8 12
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 135 Pseudoephedrine HCL
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column 3.9 x 20 mm, 5 µm Part numbers: Column - WAT046970, Guard - WAT054250 Mobile phase: 50mM potassium phosphate, pH 3.0/acetonitrile 85:15 Flow rate: 1.0 mL/min Injection volume: 5 µL of 2.88 µg/mL sample Detection: UV @ 261 nm
USP Tailing Factors 1. 1.65
1. Pseudoephedrine HCL
Minutes
136 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Pseudoephedrine HCL and Chlorpheniramine
HPLC Method
® Column: Symmetry C18, 3.9 x 150 mm, 5 µm Part number: WAT046970 Mobile phase A: 50 mM potassium phosphate, pH 3.0 Mobile phase B: Acetonitrile Gradient: Time Profile (min) %A %B 08515 18515 15 50 50 Flow rate: 1.0 mL/min Injection volume: 5 µL of 1.8 mg/mL pseudoephedrine and 120 µg/mL chlorpheniramine sample Detection: UV @ 261 nm
USP Tailing Factors 1. 1.7 2. 1.2
1. Pseudoephedrine HCL
2. Chlorpheniramine Maleate
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 137 Pseudoephedrine HCL and Triprolidine HCL
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column 3.9 x 20 mm, 5 µm Part numbers: Column - WAT046970, Guard - WAT054250 Mobile phase A: 50 mM potassium phosphate, pH 3.0 Mobile phase B: Acetonitrile Gradient: Time Profile (min) %A %B 08515 18515 15 50 50 Flow rate: 1.0 mL/min Injection volume: 5 µL of 2.88 µg/mL pseudoephedrine and 120 µg/mL triprolidine extracted tablet sample Detection: UV @ 261 nm
USP Tailing Factors 1. 1.53 2. 1.16
1. Pseudoephedrine HCL
2. Triprolidine HCL
Minutes
138 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Pseudoephedrine HCL and Codeine
HPLC Method
™ Column: SymmetryShield RP8, 3.9 x 150 mm, 5 µm Part Number: WAT200655 Mobile phase A: 50 mM potassium phosphate, pH7 Mobile phase B: Acetonitrile Gradient: Time Profile (min) %A %B 08515 15 50 50 Flow rate: 1 mL/min Injection Volume: 5 µL of 2 mg/mL pseudoephedrine HCL and 0.2 mg/mL codeine Detection: UV @ 254 nm
USP Tailing Factors 1. 1.8 2. 1.1
1. Pseudoephedrine HCL
2. Codeine
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 139 Purine Alkaloids
HPLC Method Oasis® HLB Extraction Method Oasis® HLB 1 cc/30 mg Extraction Cartridge ™ Part Number WAT094225 Column: SymmetryShield RP8, 3.9 x 150 mm, 5 µm ™ Guard Column: Sentry guard column, 3.9 x 20 mm, 5 µm Condition 1 mL methanol/1 mL water Part Numbers: Column - WAT094243, Guard - WAT200675 Mobile phase: 20 mM ammonium acetate, pH 5/acetonitrile, 95:5 Load 1 mL porcine serum with 0.2 µg Flow rate: 0.6 mL/min ß-hydroxyethyltheophylline (I.S.) Temperature: 25˚ C Wash Injection volume: 20 µL of reconstituted porcine serum extract 1 mL water Detection: UV @ 273 nm Elute 1 mL methanol Compounds: Evaporate and Reconstitute 1: Theobromine 40 ˚C under nitrogen stream 2: Paraxanthine 200 µL mobile phase 3: Theophylline 4: b-hydroxyethyltheophylline (I.S.) 5: Caffeine
1. Theobromine 2. Paraxanthine 3. Theophylline
O CH2CH2OH O CH2
H3C H3C N N N N
N N O N O N
CH3 CH3
4. ß-hydroxyethyltheophylline (I.S.) 5. Caffeine
Chromatogram of Serum Extracts: A) Blank B) Spiked Sample
1
3 Compound Concentration % Recovery %RSD 0.03 AU 2 µg/mL (n=6) Theobromine 0.100 103.0% 3.4% 5 0.500 104.0% 2.4% Paraxanthine 0.100 101.0% 6.2% 4 0.500 98.9% 2.3% Theophylline 0.100 100.0% 5.2% B 0.500 101.0% 2.1% A Caffeine 0.100 92.6% 4.4% 0.500 97.5% 3.2% 0 5 10 15
140 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Quinidine Sulfate and Related Substance
HPLC Method
™ Column: SymmetryShield RP18, 4.6 x 250 mm, 5 µm Part Number: 186000112 Mobile phase: 860 mL water, 20 mL methanesulfonic acid sloution, 20 mL diethylamine solution, 100 mL acetonitrile; pH adjusted to 2.6 with diethylamine solution Diethylamine solution: 10 mL diethylamine in 100 mL water Methanesulfonic acid solution: 14 mL methanesulfonic acid and 8 mL glacial acetic acid in 200 mL water Flow rate: 1.0 mL/min Injection volume: 50 µL Detection: UV @ 235 nm
USP Tailing Factor 1. 1.76 2. 1.33
1. Quinidine sulfate 2. Dihydroquinidine sulfate
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 141 ™ Ranitidine (SymmetryShield RP18)
HPLC Method
™ Column: SymmetryShield RP18, 4.6 x 150 mm, 5 µm Part Number: 18600109 Mobile phase: 20 mM phosphate buffer, pH 7.0/acetonitrile, 85:15 Flow rate: 1.0 mL/min Injection volume: 5 µL Detection: UV @ 254 nm
USP Tailing Factor 1. 1.07
1
1. Ranitidine
Minutes
142 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. ® Ranitidine (Symmetry C8)
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column 3.9 x 20 mm, 5 µm Part numbers: Column - WAT046970, Guard - WAT054250 Mobile phase: 100 mM sodium acetate, 5mM camphosulfonic acid, pH 6.2/ acetonitrile/methanol 80:10:10 Flow rate: 1.0 mL/min Injection volume: 5 µL of 100 µg/ml sample Detection: UV @ 254 nm
USP Tailing Factor 1. 1.12
1. Ranitidine
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 143 Ranitidine in Serum
HPLC Method Oasis® HLB Extraction Method Oasis® HLB 1 cc/30mg Extraction Cartridge ™ Column: SymmetryShield RP8, 3.9 x 150 mm, 5 µm Part Number WAT094225 Guard Column: Sentry™ guard column, 3.9 x 20 mm, 5 µm Part numbers: Condition Column - WAT200655, Guard - WAT200675 1 mL methanol/1 mL water Mobile phase: 20 mM potassium phosphate, pH 3.0/methanol 97:3
Flow rate: 1.0 mL/min Load Injection volume: 50 µL of reconstituted porcine serum extract 1 mL spiked porcine serum Temperature: 30˚ C Wash Detection: UV @ 220 nm 1 mL 5% methanol in water
Compounds: Elute 1: Sulfanilamide (I.S.) 1 mL methanol 2: Ranitidine Evaporate and Reconstitute 40 ˚C under nitrogen stream 200 µL of 50 µg/mL sulfanilamide (I.S.) in water
H3C H O H N N N S CH3
H3C CHNO2 1. Sulfanilamide 2. Ranitidine
Chromatogram of Serum Extracts: A) Blank B) Spiked Sample
Compound Concentration % Recovery %RSD µg/mL (n=6)
Ranitidine 0.100 104% 1.9% 0.500 102% 1.7%
Minutes
144 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Salicylic Acid and Related Compounds in Serum
HPLC Method Oasis® HLB Extraction Method Oasis® HLB 1 cc/30 mg Extraction Cartridge ™ Column: SymmetryShield RP8, 3.0 x 150 mm, 5 µm Part Number WAT094225 Guard Column: Sentry™ guard column, 3.9 x 20 mm, 5 µm Condition Part numbers: Column - WAT094243, Guard - WAT200675 1 mL methanol/1 mL water Mobile phase: 1.2% glacial acetic acid/acetonitrile 75:25 Flow rate: 0.6 mL/min Load Injection volume: 10 µL of reconstituted porcine serum extract 1 mL spiked porcine serum acidified with 20 µL phosphoric acid Temperature: 40˚ C
Detection: UV @ 236 nm Wash 1 mL 5% methanol in water Compounds: 1: Benzoic acid Elute 1 mL methanol 2: Nalidixic acid (I.S.)
3: Salicylic acid Evaporate and Reconstitute 40 ˚C under nitrogen stream 1 mL 5 µg/mL nalidixic acid in mobile phase
1. Benzoic acid 2. Nalidixic acid (I.S.) 3. Salicylic acid
Chromatogram of Serum Extracts: A) Blank B) Spiked Sample
1 Compound Concentration % Recovery %RSD µg/mL (n=6)
2 Benzoic Acid 0.100 84.8% 3.8% 0.500 87.1% 3.0% Salicylic Acid 0.100 92.3% 5.0% 3 0.500 91.3% 3.3%
0.035 AU B
A
0 5 10 15 MinutesMinutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 145 Salicylic Acid and Related Compounds
HPLC Method
® Column: Symmetry C18,3.9 x 150 mm, 5 µm Part number: WAT046980 Mobile phase: 50 mM potassium phosphate pH 3.0/acetonitrile 70:30 Temperature: 40˚ C Flow rate: 0.7 mL/min Injection volume: 6 µL of phthalic acid (0.5 mg/mL), benzoic and salicylic acids (1 mg/mL) Detection: UV @ 254 nm
USP Tailing Factors 1. 1.7 2. 1.1 3. 1.4
1. Phthalic Acid
2. Salicylic Acid
3. Benzoic Acid
Minutes
146 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Speed Mix - 2.1 x 20 mm Intelligent Speed™ Separation
HPLC Method
® ™ O Columns: Symmetry C18,2.1 x 20 mm, 3.5 µm IS O ™ ™ SymmetryShield RP18,4.6 x 20 mm, 3.5 µm IS NH H3C Part numbers: Symmetry - 186002066 O 3. Acetanilide SymmetryShield - 186002068 1. Theophylline 2. 2-Acetylfuran Mobile phase A: 0.1% HCOOH in Water O Mobile phase B: 0.1% HCOOH in ACN O O
Gradient: Time Profile CH3 (min) %A %B 0 100 0 4. Aceophenone 5. Propiophenone 6. Butyrophenone 40 100 Flow rate: 0.6 mL/min O O O Injection volume: 5 µL Temperature: 30˚ C Detection: UV @ 254 nm 7. Benzophenone 8. Valerophenone 9. Hexanophenone
O O
10. Heptanophenone 11. Octanophenone
® Symmetry C18, 3.5µm Compounds: 7 1. Theophylline 2 4 2. 2-Acetylfuran 3. Acetanilide 6 8 4. Acetophenone t0 = 0.17 min 1 3 5 91110 5. Propiophenone Max PSI = 1247 6. Butyrophenone 7. Benzophenone 8. Valerophenone 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 9. Hexanophenone 10. Heptanophenone Minutes 11. Octanophenone
™ 7 SymmetryShield RP18, 3.5µm
2 4 6 1 8 11 5 9 10 t0 = 0.17 min 3 Max PSI = 1452
0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 147 Speed Mix - 4.6 x 20 mm Intelligent Speed™ Separation
HPLC Method
® ™ O Columns: Symmetry C18,4.6 x 20 mm, 3.5 µm IS O SymmetryShield™ RP ,4.6 x 20 mm, 3.5 µm IS™ 18 NH H3C Part numbers: Symmetry - 186002090 O SymmetryShield - 186002092 1. Theophylline 2. 2-Acetylfuran 3. Acetanilide Mobile phase A: 0.1% HCOOH in Water O Mobile phase B: 0.1% HCOOH in ACN O O
Gradient: Time Profile CH3 (min) %A %B 0 100 0 4. Aceophenone 5. Propiophenone 6. Butyrophenone 40 100 Flow rate: 3.0 mL/min Injection volume: 10 µL O O O Temperature: 30˚ C Detection: UV @ 254 nm 7. Benzophenone 8. Valerophenone 9. Hexanophenone
O O
10. Heptanophenone 11. Octanophenone
® Symmetry C18, 3.5µm Compounds: 7 1. Theophylline 2. 2-Acetylfuran 2 4 3. Acetanilide 4. Acetophenone 6 11 8 9 5. Propiophenone 1 5 6. Butyrophenone t0 = 0.15 min 3 10 7. Benzophenone Max PSI = 1162 8. Valerophenone 9. Hexanophenone 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 10. Heptanophenone 11. Octanophenone Minutes
™ SymmetryShield RP18, 3.5µm 7
2 4 1 6 11 3 8 9 5 10 t0 = 0.16 min Max PSI = 1124
0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00
Minutes
148 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Steroids
HPLC Method
® Column: Symmetry C8 ,3.9 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column 3.9 x 20 mm, 5 µm Part numbers: Column - WAT046970, Guard - WAT054250 Mobile phase: Acetonitrile/water 50:50 Flow rate: 1.0mL/min Injection volume: 5µL of 10 µg/mL sample Detection: UV @ 254nm
USP Tailing Factors 1. 1.08 Vo: Uracil 2. 1.18 3. 1.10 4. 1.31
1. Prednisolone
2. Betamethasone
3. Prednisolone Acetate
Minutes
4. Betamethasone Valerate
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 149 Steroids in Serum
HPLC Method Oasis® HLB Extraction Method Oasis® HLB 1 cc/30 mg Extraction Cartridge ™ Column: SymmetryShield RP8, 3.9 x 150 mm, 5 µm Part Number WAT094225 ™ Guard Column: Sentry guard column, 3.9 x 20 mm, 5 µm Condition Part numbers: Column - WAT200655, Guard - WAT200675 1 mL methanol/1 mL water Mobile phase: 20 mM potassium phosphate, pH 7/methanol 41:59 Load Flow rate: 1.0 mL/min 1 mL spiked porcine serum Injection volume: 5 µL of reconstituted porcine serum extract Detection: UV @ 254 nm Wash 1 mL 5% methanol in water
Compounds: Elute 1 mL methanol, added 50 µL of 1: Prednisolone 0.1 mg/mL butyl paraben (I.S.) 2: Betamethasone 3: Butyl Paraben (I.S.) Evaporate and Reconstitute 40 ˚C under nitrogen stream 4: Betamethasone Valerate 200 µL acetonitrile
1. Prednisolone 2. Betamethasone 3. Butyl Paraben (I.S.) 4. Betamethasone valerate
Chromatogram of Serum Extracts: A) Blank B) Spiked Sample
3 2 0.05 AU 1 4
Compound Concentration % Recovery %RSD µg/mL (n=6)
Prednisolone 1.00 93.8% 4.7% 5.00 92.0% 1.4%
Betamethasone 1.00 85.7% 2.3% 5.00 91.3% 1.5% B Betamethasone 4.00 95.4% 2.2% A Valerate 20.00 90.6% 1.3% 0481216 MinutesMinutes
150 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Steroids - 2.1 x 20 mm Intelligent Speed™ Separation
HPLC Method
® ™ Column: Symmetry C18,2.1 x 20 mm, 3.5 µm IS Part number: 186002066 Mobile phase A: Water Mobile phase B: ACN Gradient: Time Profile (min) %A %B 08020 43664 Flow rate: 0.6 mL/min Injection volume: 5 µL Temperature: 30˚ C Detection: UV @ 220 nm
O O OH CH3 CH HO 3 OH O OH CH3 H CH3 H
H H H H O O
1. Prednisolone 2. Cortisone 3. Corticosterone
H3C O O CH3 CH3 OH CH3 CH H H 3 H H H H H H H O HO HO
4. Estradiol 5. Estrone 6. Progesterone
® Symmetry C18, 3.5µm 2 Compounds: 1 3 4 5 1. Prednisolone 6 2. Cortisone 3. Corticosterone t0 = 0.33 min Max PSI = 1280 4. Estradiol 5. Estrone 6. Progesterone 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 151 Steroids - 4.6 x 20 mm Intelligent Speed™ Separation
HPLC Method
® ™ Columns: Symmetry C18,4.6 x 20 mm, 3.5 µm IS ™ ™ SymmetryShield RP18,4.6 x 20 mm, 3.5 µm IS Part numbers: Symmetry - 186002090 SymmetryShield - 186002092 Mobile phase A: Water Mobile phase B: ACN Gradient: Time Profile O (min) %A %B O OH CH3 CH HO 08020 3 OH O OH 43664 CH3 H CH3 H Flow rate: 3.0 mL/min H H Injection volume: 10 µL H H O Temperature: 30˚ C O Detection: UV @ 220 nm 1. Prednisolone 2. Cortisone 3. Corticosterone
H3C O O CH3 CH3 OH CH3 CH H H 3 H H H H H H H O HO HO
4. Estradiol 5. Estrone 6. Progesterone
23 1 5 ® 6 Symmetry C18, 3.5µm 4
t0 = 0.14 min Max PSI = 1190
Compounds 1. Prednisone 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 2. Cortisone 3. Corticosterone Minutes 4. Estradiol 5. Estrone 23 6. Progesterone 1 5 ™ 6 SymmetryShield RP18, 3.5µm 4
t0 = 0.14 min Max PSI = 1132
0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00
Minutes
152 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Succinimides
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column 3.9 x 20 mm, 5 µm Part numbers: Column - WAT046970, Guard - WAT054250 Mobile phase: 100 mM potassium phosphate, pH 6.9/methanol/water 20:30:50 Flow rate: 1.0 mL/min Injection volume: 10 µL of 40-500µg/mL sample Detection: UV @ 214 nm
USP Tailing Factors 1. 0.96 2. 0.92 3. 0.91
1. Ethosuximide
2
1 2. Phensuximide
3
3. Methsuximide
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 153 Sulfa Drugs
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5µm Guard Column: Sentry™ Guard Column 3.9 x 20 mm, 5µm Part numbers: Column - WAt046970, Guard - WAT054250 Mobile phase: Water/methanol/glacial acetic acid 79:20:1 Flow rate: 1.0 mL/min Injection volume: 10 µL of sample with components at 10 to 39 µg/mL Detection: UV @ 254 nm
USP Tailing Factors O NH S NH 1. 1.27 2 N O 2. 1.19 N 3. 1.18 4. 1.15 1. Sulfanilamide 2. Sulfadiazine 5. 1.12 6. 1.11
NH2
N O H2N S O S H C N NH 3 O S NH N O
3. Sulfathiazole 4. Sulfamerazine
5. Sulfamethazine 6. Succinylsulfathiazole
154 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Sulfa Drugs in Serum
HPLC Method Oasis® HLB Extraction Method Oasis® HLB 1 cc/30 mg Extraction Cartridge ® Column: Symmetry C18, 3.9 x 150 mm, 5 µm Part Number WAT094225 Part number: WAT046980 Condition Mobile phase: 1% glacial acetic acid and 4% methanol in water 1 mL methanol/1 mL water Flow rate: 1.0 mL/min Injection volume: 10 µL of reconstituted porcine serum extract Load 1 mL spiked porcine serum Temperature: 25˚ C with 10 µg/mL sulfathiazole (I.S.), Detection: UV @ 254 nm 20 µL phosphoric acid
Compounds: Wash 1 mL 5% methanol in water 1: Sulfadiazine
2: Sulfathiazole (I.S.) Elute 3. Sulfamerazine 1 mL methanol
Evaporate and Reconstitute 40 ˚C under nitrogen stream 1 mL mobile phase
O
NH NH S NH2 2 H2N N O N O O S N S S H3C N NH NH N O O
1. Sulfadiazine 2. Sulfathiazole (I.S.) 3. Sulfamerazine
Chromatogram of Serum Extracts: A) Blank B) Spiked Sample
Compound Concentration % Recovery %RSD 1 µg/mL (n=6)
Sulfadiazine 2.00 98.4% 2.7% 10.0 96.9% 0.65% Sulfamerazine 2.00 93.5% 1.9% 2 10.0 96.4% 0.74% 3
0.004 AU
B
A
5 10 15 MinutesMinutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 155 Sulfa Drugs - 2.1 x 20 mm Intelligent Speed™ Separation
HPLC Method
® ™ Column: Symmetry C18,2.1 x 20 mm, 3.5 µm IS Part number: 186002066 Mobile phase A: 0.1% HCOOH in Water Mobile phase B: 0.1% HCOOH in MeOH Gradient: Time Profile (min) %A %B 0 100 0
45050 O
H N NH Flow rate: 0.6 mL/min NH S NH2 2 2 S Injection volume: 10 µL N O O N O N S S Temperature: 30˚ C N NH H3C N NH Detection: UV @ 270 nm O O 1. Sulfadiazine 2. Sulfathiazole 3. Sulfamerazine Compounds: H3C N NH2 H C 1. Sulfadiazine 3 O CH3 NH2 2. Sulfathiazole O O N O O H C 3. Sulfamerazine S 3 NH S NH2 S N NH H3C N NH O 4. Sulfadimidine O O 5. Sulfamethoxazole 4. Sulfadimidine 5. Sulfamethoxazole 6. Sulfisoxazole 6. Sulfisoxazole 7. Sulfadimethoxine
H3C O NH2
N N O
H3C S O NH O
7. Sulfadimethoxine
® Symmetry C18, 3.5µm 1 5 2 3 67 4 t0 = 0.17 min Max PSI = 2050
0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00
Minutes
156 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Sulfa Drugs - 4.6 x 20 mm Intelligent Speed™ Separation
HPLC Method
® ™ Column: Symmetry C18,4.6 x 20 mm, 3.5 µm IS Part number: 186002090 Mobile phase A: 0.1% HCOOH in Water Mobile phase B: 0.1% HCOOH in MeOH Gradient: Time Profile (min) %A %B 0 100 0
45050 O
Flow rate: 3.0 mL/min H N NH NH S NH2 2 2 Injection volume: 10 µL S N O O N O Temperature: 30˚ C N S S N NH H3C N NH Detection: UV @ 270 nm O O 1. Sulfadiazine 2. Sulfathiazole 3. Sulfamerazine Compounds:
H3C 1. Sulfadiazine NH2 CH N 3 H3C NH2 O 2. Sulfathiazole O O N O O 3. Sulfamerazine S H C S N NH 3 NH S NH2 4. Sulfadimidine H3C N NH O O O 5. Sulfamethoxazole 5. Sulfamethoxazole 6. Sulfisoxazole 6. Sulfisoxazole 4. Sulfadimidine 7. Sulfadimethoxine
H3C O NH2
N N O
H3C S O NH O
7. Sulfadimethoxine
1 ® Symmetry C18, 3.5µm
2 3 5 6 7 4
t0 = 0.15 min Max PSI = 2280
0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 157 Sulfamethoxazole and Trimethoprim
HPLC Method
® Column: Symmetry C18, 3.9 x 150 mm, 5 µm Part number: WAT046980 Mobile phase: Water/methanol/glacial acetic acid 79:20:1 Flow rate: 1.0 mL/min Injection volume: 10 µL of 100 µg/mL sulfamethoxazole and 30 µg/mL trimethroprim Detection: UV @ 254 nm
USP Tailing Factors 1. 1.5 2. 1.1
1. Trimethoprim
2. Sulfamethoxazole
Minutes
158 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Sulfamethoxazole and Trimethoprim in Serum
HPLC Method Oasis® HLB Extraction Method Oasis® HLB 1 cc/30 mg Extraction Cartridge ® Column: Symmetry C18, 3.9 x 150 mm, 5 µm Part Number WAT094225 Guard Column: Sentry™ guard column, 3.9 x 20 mm, 5 µm Part number: Column - WAT046980 Condition 1 mL methanol/1 mL water Mobile phase: 25 mM ammonium acetate, pH 5/methanol 82:18 (v/v)
Flow rate: 1.0 mL/min Load Injection volume: 20 µL of reconstituted porcine serum extract 1 mL spiked porcine serum with 20 µL phosphoric acid and Detection: UV @ 290 nm 2.5 µg/mL sulfamerazine (I.S.)
Compounds: Wash 1: Sulfamerazine (I.S.) 1 mL 5% methanol in water 2: Trimethoprim 3: Sulfamethoxazole Elute 1 mL methanol
Evaporate and Reconstitute 40 ˚C under nitrogen stream 200 µL mobile phase
1. Sulfamerazine (I.S.) 2. Trimethoprim 3. Sulfamethoxazole
Chromatogram of Serum Extracts: A) Blank B) Spiked Sample
3 Compound Concentration % Recovery %RSD 1 µg/mL (n=6)
Sulfamethoxazole 1.20 90.4% 1.3% 0.240 95.4% 3.4% Trimethoprim 1.50 96.7% 1.1% 2 0.300 99.3% 3.2% 00.02 AU
B.
A.
`51015 20 Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 159 ® Symmetry C18 pH 3 Batch Test
HPLC Method
® Column: Symmetry C18,3.9 x 150 mm, 5 µm Part number: WAT046980 Mobile phase: 50 mM potassium phosphate pH 3.0/acetonitrile 80:20 Flow rate: 1.0 mL/min Injection volume: 20 µL of mixture with chlorpheniramine, maleate, toluamide and propranolol Detection: UV @ 230 nm
Compounds 1. Maleate 2. Toluamide 3. Chlorpheniramine 4. Propranolol
1. Maleate
2. Toluamide
3. Chlorpheniramine
CH3
O N CH3 H OH
4. Propranolol
Minutes
160 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Synthetic Antibiotics
HPLC Method
® Column: Symmetry C18, 3.9 x 150 mm, 5 µm Part number: WAT046980 Mobile phase: 0.1% phosphoric acid in water/methanol 62:38 Flow rate: 1.0 mL/min Injection volume: 10 µL of mixture with 30 µg/mL furazolidone and oxolinic acid and 100 µg/mL nolidixic acid Detection: UV @ 254 nm
USP Tailing Factors 1. 1.2 2. 1.1 3. 1.2
1. Furazolidone
2. Oxolinic Acid
3. Nalidixic Acid
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 161 Tamoxifen
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Part number: WAT046970 Mobile phase: 50 mM potassium phosphate, pH 3/acetonitrile 55:45 Flow rate: 1.0 mL/min Injection volume: 5 µL of 100 µg/mL Detection: UV @ 254 nm
USP Tailing Factors 1. 1.3
1. Tamoxifen Citrate
Minutes
162 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Tamoxifen- Isolation of Impurities, Transfer from Analytical to Prep
HPLC Method
® Columns: Symmetry C18, 3.0 x 150 mm, 5 µm ™ SymmetryPrep C18, 7.8 x 300 mm, 7 µm Part numbers: Symmetry - WAT054200 SymmetryPrep - WAT066235 Mobile phase: Acetonitrile/50 mM potassium phosphate buffer, pH 3.0 40:60 Flow rate: A. 0.4 mL/min B. 5.6 mL/min Injection volume: 5 mg/mL tamoxifen citrate A. 15 mg B. 101mg Detection: UV @ 254 nm
1. Tamoxifen Citrate
1
® 1. Symmetry C18 , 5 µm, 3.0 mm x 150 mm
™ 1. SymmetryPrep C18 , 7 µm, 7.8 mm x 300 mm
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 163 Terfenadine
HPLC Method
™ Column: SymmetryShield RP18, 4.6 x 150 mm, 5 µm Part number: 186000109 Mobile phase: 20 mM phosphate buffer, pH 7.0/acetonitrile 25:75 Flow rate: 1.0 mL/min Injection volume: 5 µL Detection: UV @ 220 nm
USP Tailing Factor 1. 1.04
1. Terfenadine
Minutes
164 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Terfenadine and Related Compound
HPLC Method
® Column: Symmetry C8, 4.6 x 250 mm, 5 µm Part number: WAT054270 Mobile phase: 100 mM triethylammonium phosphate, pH 7.0/methanol 20:80 Flow rate: 1.0 mL/min Injection volume: A. 15 µL of mixture with 0.6 mg/mL terfenadine and 0.15 mg/mL of terfenadine related compound ARS B.15 µL of 8mg/mL crushed tablet ( equivalent to 0.6mg/mL terfenadine) Detection: UV @ 235 nm
Compounds: 1. Terfenadine 2. Terfenadine Related Compound ARS
USP Tailing Factor 1. 1.0
Tablet:
1. Terfenadine
Standard:
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 165 Testosterone Esters in Serum
HPLC Method Oasis® HLB Extraction Method ® Oasis HLB 1 cc/30 mg Extraction Cartridge ® Part Number WAT094225 Column: Symmetry C8, 4.6 x 75 mm, 3.5 µm ™ Guard Column: Sentry guard column, 3.9 x 20 mm, 5 µm Condition Part Numbers: Column - WAT066224, Guard - WAT064225 1 mL methanol/1 mL water
Mobile phase: Acetonitrile/water 60:40 Load Flow rate: 1 mL sample with 800 µL spiked porcine 1.5 mL/min serum and 200 µL of methanol Injection Volume: 20 µL of reconstituted porcine serum extract Detection: UV @ 254 nm Wash 1 mL 5% methanol in water
Compounds: Elute 1 mL methylene chloride: 1: Testosterone acetate methanol 50:50 (v/v) 2: Testosterone propionate Evaporate and Reconstitute 3: Testosterone benzoate 40 ˚C under nitrogen stream 500 µL methanol with 5 µg/mL 4: Testosterone enanthate (I.S.) of testosterone enanthate
1. Testosterone acetate 2. Testosterone propionate 3. Testosterone benzoate 4. Testosterone enanthate (I.S.)
Chromatogram of Serum Extracts: A) Blank B) Spiked Sample
1
2
3 Compound Concentration % Recovery %RSD 4 µg/mL (n=6)
Testosterone 1.00 98% 1.2% Acetate 0.200 94% 3.7% Testosterone 1.00 100% 1.9% 0.008 AU Propionate 0.200 94% 4.3% B Testosterone 1.00 94% 1.6% A Benzoate 0.200 87% 3.2%
0 10 20 MinutesMinutes
166 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Tetracyclines
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column 3.9 x 20 mm, 5 µm Part numbers: Column - WAT046970, Guard - WAT054250 Mobile phase: 10 mM sodium phosphate, pH 6.25/methanol 45:55 Flow rate: 1.0 mL/min Injection volume: 20 µL of 500 µg/mL sample Detection: UV @ 280 nm
USP Tailing Factors 1. 1.05 2. 1.29 3. 1.14
1. Doxycycline
2. Minocycline
3. Tetracycline
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 167 Tetracyclines in Serum
HPLC Method Oasis® HLB Extraction Method Oasis® HLB 1 cc/30 mg Extraction Cartridge ™ Column: SymmetryShield RP8, 3.0 x 150 mm, 5 µm Part Number WAT094225 Guard Column: Sentry™ guard column, 3.9 x 20 mm, 5µm Condition Part numbers: Column - WAT094243, Guard - WAT200675 1 mL methanol/1 mL water Mobile phase: 0.1% TFA in Water, Methanol, Acetonitrile 91:2:7 Flow rate: 0.90 mL/min Load 1 mL spiked porcine serum Injection volume: 20 µL of reconstituted porcine serum extract with 20 µL phosphoric acid and Detection: UV @ 350 nm 5.0 µg/mL demeclocycline (I.S.)
Compounds: Wash 1 mL 5% methanol in water 1: Minocycline 2: Tetracycline Elute 3: Demeclocycline (I.S.) 1 mL methanol
Evaporate and Reconstitute 40 ˚C under nitrogen stream 200 µL mobile phase
1. Minocycline 2. Tetracycline 3. Demeclocycline (I.S.)
Chromatogram of Serum Extracts: A) Blank B) Spiked Sample
1
2
3 Compound Concentration % Recovery %RSD µg/mL (n=6)
0.006 Minocycline 2.50 96.1% 1.3% 0.500 88.0% 1.6%
B Tetracycline 2.50 101.0% 0.5% A 0.500 97.8% 1.4%
10 20 30
Minutes
168 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Theophylline and Related Compounds
HPLC Method
™ Column: SymmetryShield RP18, 3.0 x 150 mm, 5 µm Part number: 186000692 Mobile phase: 5 mM potassium phosphate, pH 2.0/acetonitrile 95:5 Flow rate: 0.6 mL/min Injection volume: 5 µL injection of solution containing theobromine (0.22 mg/mL), theophylline (0.26 mg/mL), and 7-(2-hydroxyethyl) theophylline (0.13 mg/mL) Detection: UV @ 270 nm
1. Theobromine
2. Theophylline
3. 7-(2-hydroxyethyl) Theophylline
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 169 Theophylline and Theobromine
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column 3.9 x 20mm, 5 µm Part numbers: Column - WAT046970, Guard - WAT054250 Mobile phase: 10 mM potassium phosphate, pH7.0/ methanol 76:24 Flow rate: 1.0 mL/min Injection volume: 20 µL of 10 µg/mL sample Detection: UV @ 280 nm
USP Tailing Factors 1. 1.18 2. 1.03 3. 1.01
1. Theobromine
2. Theophylline
O CH2
H3C N N
N O N
CH3
3. Caffeine
Minutes
170 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Trazodone
HPLC Method
™ Column: SymmetryShield RP8, 3.9 x 150 mm, 5 µm Part number: 186000108 Mobile phase: 50 mM phosphate, pH7.0/methanol 36:64 Flow rate: 1.0 mL/min Injection volume: 25 µL Detection: UV @ 250 nm
USP Tailing Factors 1. 1.31 2. 1.21 3. 1.12
1. 1-(3-chlorophenyl)peperazine
2. Maprotiline (I.S.)
3. Trazodone
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 171 Triazine Herbicides in Drinking Water
HPLC Method Oasis® HLB Extraction Method Conditions for Oasis® HLB Cartridge, 3 cc, 60 mg
™ Part Number WAT094226 Column: SymmetryShield RP8, 3.9 x 150 mm, 5 µm Part number: WAT0200655 Condition: 3 mL methanol Rinse: 3 mL H2O Mobile Phase A: 5 mM phosphate buffer, pH 6.7/Acetonitrile 85:15 Mobile Phase B: Acetonitrile Load: 75 mL sample @ 4 mL/min Gradient: Time Profile (min) %A %B Wash: 1 mL H O 0 100 0 2 2 100 0 Elute: 25 30 70 1.2 mL methanol Flow Rate: 1.0 mL/min Evaporate to 0.2 mL Injection volume: 75 µL Detection: UV @ 214 nm (0.02 AUFS) Reconstitute to exactly 1.0 mL with H2O
1. Desisopropylatrazine 2. Hydroxyatrazine 3. Desethylatrazine
4. Simazine 5. Cyanazine 6. Atrazine
spiked well water Compounds % Recovery Tap Water Tap Water Spike Level Spike Level 500 µg/L 200 ng/L 5 replicates 7 replicates 1. Desisopropylatrazine 98.4 (5.0) 95.6 (5.8) 3 5 6 2. Hydroxyatrazine 132 (1.3) 109 (11) 4 3. Desethylatrazine 106 (5.1) 104 (4.0) 2 4. Simazine not determined 97.7 (3.9) 5. Cyanazine not determined 93.1 (3.7) 1 6. Atrazine 101 (5.0) 101 (4.4) nonspiked sample
blank cartridge
05MinutesMinutes 10 15
172 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Tricyclic Antidepressants
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Part number: WAT046980 Mobile phase: 20 mM potassium phosphate, pH 7/methanol 35:65 Flow rate: 1.0 mL/min Injection volume: 20 µL of 100 µg/mL sample 1. Protriptyline HCL Detection: UV @ 254 nm
USP Tailing Factors 1. 1.7 2. 1.7 3. 1.8 4. 1.5 5. 1.4 6. 1.2 2. Nortriptyline HCL
3. Doxepin HCL
4. Imipramine HCL
5. Amtriptyline HCL
6. Trimipramine Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 173 Tricyclic Antidepressants and Metabolites
HPLC Method
® Column: Symmetry C18, 3.9 x 150 mm, 5 µm Part number: WAT046980 Mobile phase: 20 mM potassium phosphate, pH 7.0/methanol 29:71 Flow rate: 1.0 mL/min Injection volume: 5 µL of 1 to 1.16 mg/mL Temperature: 35˚ C Detection: UV @ 254 nm
USP Tailing Factors 1. 1.5 2. 1.5 3. 1.3 4. 1.2
1. Nordoxepin HCL
2. Doxepin HCL
3. Nortriptyline HCL
4. Amtriptyline HCL
Minutes
174 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Tricyclic Antidepressants in Plasma
HPLC Method Oasis® HLB Extraction Method Oasis® HLB Extraction Plate, 30 mg/96-well ™ Part Number WAT058951 Column: SymmetryShield RP8, 4.6 x 75 mm, 3.5 µm
Part number: WAT094263 Condition Mobile phase: 50 mM phosphate, pH 7/methanol 26:74 1 mL methanol/1 mL water Flow rate: 1.4 mL/min Load Injection volume: 1 mL spiked plasma plus 20 µL concentrated phosphoric acid, 100 µL injection 1 mL spiked plasma plus 20 µL concentrated phosphoric acid Temperature: 29˚ C
Detection: UV @ 254 nm Wash A. 1 mL 2% ammonium hydroxide in 5% methanol Compounds: B. 1 mL 2% ammonium hydroxidein 65% methanol Spiked at 500 ng/mL versus Blank: C. 1 mL 2% acetic acid in 5% methanol 1. Nordoxepin (I.S.)
2. Nortriptyline Elute 3. Doxepin 600 µL 65% methanol 4. Imipramine Add internal standard (I.S.) 5. Amitriptyline 60 µL 36 µg/mL nordoxepin in 6. Trimipramine 10% ammonium hydroxide
1. Nordoxepin 2. Nortriptyline 3. Doxepin
4. Imipramine 5. Amitriptyline 6. Trimipramine
Chromatogram of Plasma Extracts: A) Blank B) Spiked Sample
500 ng/mL 100 ng/mL
Compound Recovery RSD Recovery RSD 1 (n=96) (n=95) 4 2 3 Nortriptyline 92.3% 1.4% 90.8% 5.7% Doxepin 90.6% 1.4% 90.4% 4.7% 5 Imipramine 92.2% 1.7% 86.4% 5.3% 6 Amitriptyline 90.2% 1.6% 85.3% 5.8% Trimipramine 90.3% 1.9% 89.8% 6.1%
0.02 AU A B
01234 Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 175 Tripelennamine
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column 3.9 x 20 mm, 5 µm Part numbers: Column - WAT046970, Guard - WAT054250 Mobile phase: 50 mM potassium phosphate, pH 3.0/acetonitrile 85:15 Flow rate: 1.0 mL/min Injection volume: 10 µL of 200 µg/mL sample Detection: UV @ 261 nm
USP Tailing Factor 1. 1.6
1. Tripelennamine
Minutes
176 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Verapamil
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column 3.9 x 20mm, 5 µm Part numbers: Column - WAT046970, Guard - WAT054250 Mobile phase: 10 mM sodium acetate with 3.3% glacial acetic acid, pH 2.6/acetonitrile 70:30 Flow rate: 1.0 mL/min Injection volume: 10 µL of 100 µg/mL sample Detection: UV @ 278 nm
USP Tailing Factor 1. 1.27
1. Verapamil
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 177 Verapamil and Norverapamil
HPLC Method
™ Column: SymmetryShield RP8, 3.9 x 150 mm, 5 µm Part number: WAT200655 Mobile phase: 50 mM phosphate pH 7.0/acetonitrile/methanol 41:37:22 Flow rate: 1.0 mL/min Injection volume: 40 µL Detection: UV @ 230 nm
USP Tailing Factors 1. 1.10 2. 1.06 3. 1.07
1. Norverapamil
2. Verapamil
3. Methoxyverapamil (I.S.)
Minutes
178 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Vitamins- Fat-Soluble
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Guard Column: Sentry™ Guard Column 3.9 x 20mm, 5 µm Part numbers: Column - WAT046970, Guard - WAT054250 Mobile phase: Methanol/acetonitrile/water 45:45:10 Flow rate: 1.0 mL/min Injection volume: 10 µL of 25 µg/mL sample Detection: UV @ 280 nm
USP Tailing Factors 1. 1.33 2. 1.20 3. 1.16 Vo. Uracil
1. Trans-Retinol (Vitamin A)
2. Cholecalciferol (Vitamin D3)
3. Alpha-Tocopherol (Vitamin E)
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 179 Vitamins- Water-Soluble
HPLC Method
® Column: Symmetry C18, 3.9 x 150 mm, 5 µm Part numbers: Column - WAT046980, PIC B6 - WAT084199 1. Niacinamide Mobile phase: 20 mM PIC B6 (hexane sulfonic acid) and 0.1% phosphoric acid, pH 2.2/methanol 75:25 Flow rate: 0.7 mL/min Injection volume: 10 µL of mixture with component 1 at 11 µg/mL, 2 at 133 µg/mL, 3 at 17 µg/mL, 4 at 6 µg/mL, 5 at 25 µg/mL, 6 at 34 µg/mL, and 7 at 67 µg/mL 2. Calcium Pantothenate Detection: UV @ 210 nm
USP Tailing Factors 1. n.c. 2. n.c. 3. 1.4 4. 1.1 5. 1.2 3. Pyridoxal 6. 1.1 7. 1.2
4. Pyrodoxine Hydrochloride
5. Pyridoxamine Dihydrochloride
6. Riboflavin
Minutes 7. Thiamine Hydrochloride
180 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Vitamins- Water-Soluble Folic Acid Mixture
HPLC Method
® Column: Symmetry C18, 3.9 x 150 mm, 5 µm Part numbers: Column - WAT046980, PIC B6 - WAT085140 Mobile phase: 20 mM PIC B6 (hexane sulfonic acid) and 0.1% phosphoric acid, pH 2.2/methanol 75:25 Flow rate: 0.7 mL/min Injection volume: 10 µL of mixture with 0.02 to 0.17 mg/mL Temperature: 40˚ C Detection: UV @ 280 nm
USP Tailing Factors 1. 1.6 2. 1.4 3. 1.2 1. Nicergoline 4. 1.2
2. Folic Acid
3. Riboflavin
4. Thiamine Hydrochloride
Minutes
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 181 Zidovudine (AZT)
HPLC Method
® Column: Symmetry C8, 3.9 x 150 mm, 5 µm Part number: WAT046970 Mobile phase: 50 mM potassium phosphate, pH 4.6/methanol 85:15 Flow rate: 1.0 mL/min Injection volume: 20 µL of 100 µg/mL sample Detection: UV @ 254 nm
USP Tailing Factor 1. 1.2
1. Zidovudine
Minutes
182 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Symmetry® Columns and Cartridges
® ® ™ Symmetry Analytical Columns Symmetry C18 PicoFrit Columns
Particle Part No. Part No. Dimension Particle Size Part Number Dimension Size C18 C8 75 µm x 50 mm 3.5 µm 186001407 1.0 x 50 mm 3.5 µm WAT106056 WAT106052 75 µm x 100 mm 3.5 µm 186001408 1.0 x 150 mm 3.5 µm WAT248059 WAT248072 75 µm x 100 mm 5 µm 186001409 2.1 x 30 mm 3.5 µm WAT058973 WAT058977 75 µm x 150 mm 5 µm 186001410 2.1 x 50 mm 3.5 µm WAT200650 WAT200624 2.1 x 100 mm 3.5 µm WAT058965 WAT058961 2.1 x 150 mm 3.5 µm WAT106005 WAT106011 ® ™ 3.0 x 100 mm 3.5 µm 186000696 186000698 Symmetry C18 IntegraFrit Columns 3.0 x 150 mm 3.5 µm 186000695 186000697 4.6 x 30 mm 3.5 µm 186000271 186000270 Dimension Particle Size Part Number 4.6 x 50 mm 3.5 µm WAT200625 WAT200620 4.6 x 75 mm 3.5 µm WAT066224 WAT066200 75 µm x 50 mm 3.5µm 186001403 4.6 x 100 mm 3.5 µm WAT066220 WAT066204 75 µm x 100 mm 3.5 µm 186001404 4.6 x 150 mm 3.5 µm WAT200632 WAT200630 75 µm x 100 mm 5 µm 186001405 75 µm x 150 mm 5µm 186001406 2.1 x 50 mm 5 µm 186000206 186000212 2.1 x 150 mm 5 µm WAT056975 WAT056955 Symmetry® Column and Cartridge Column 3.0 x 150 mm 5 µm WAT054200 WAT054230 3.0 x 250 mm 5 µm 186000690 186000691 Method Validation Kits 3.9 x 150 mm 5 µm WAT046980 WAT046970 Three Columns from Three Different Batches to Test Reproducibility. 4.6 x 50 mm 5 µm 186000207 186000213 4.6 x 150 mm 5 µm WAT045905 WAT045995 Particle Part No. Part No. 4.6 x 250 mm 5 µm WAT054275 WAT054270 Dimension Type Size C18 C8 4.6 x 150 mm Column 3.5 µm WAT094240 WAT094237 ® Symmetry Cartridge Columns (Requires endfittings, see Page 186) 2.1 x 150 mm Column 5 µm WAT094234 WAT094231 3.0 x 150 mm Column 5 µm WAT054446 WAT054434 Particle Part No. Part No. 3.9 x 150 mm Column 5 µm WAT047210 WAT046955 Dimension Size C18 C8 4.6 x 150 mm Column 5 µm WAT054448 WAT054435 4.6 x 250 mm Column 5 µm WAT054450 WAT054438 2.1 x 20 mm 3.5 µm 186000269 186000268 2.1 x 50 mm 3.5 µm 186000152 186000149 3.9 x 150 mm Cartridge* 5 µm WAT054452 WAT054440 2.1 x 100 mm 3.5 µm 186000151 186000153 4.6 x 150 mm Cartridge* 5 µm WAT054454 WAT054442 2.1 x 150 mm 3.5 µm 186000150 186000148 4.6 x 250 mm Cartridge* 5 µm WAT054456 WAT054444 4.6 x 75 mm 3.5 µm WAT066260 WAT066210 * Require Endfittings, see Page 13 4.6 x 100 mm 3.5 µm WAT066265 WAT066215 3.9 x 50 mm 5 µm WAT054220 WAT054240 SymmetryPrep™ Columns for Purification and Isolation 3.9 x 150 mm 5 µm WAT054205 WAT054235 4.6 x 150 mm 5 µm WAT054210 WAT054255 4.6 x 250 mm 5 µm WAT054215 WAT054245 Particle Part No.Part No. Dimension Size C18 C8
® ™ 7.8 x 10 mm 5 µm 186000711 186000712 Symmetry Sentry Guard Columns (2 per pack) 7.8 x 50 mm 5 µm 186000208 186000214 (Requires Sentry™ Guard Holders, see Page 186) 7.8 x 100 mm 5 µm 186000209 186000215 19 x 10 mm 5 µm 186000715 186000716 Particle Part No. Part No. 19 x 50 mm 5 µm 186000210 186000216 Dimension Size C18 C8 19 x 100 mm 5 µm 186000211 186000229 2.1 x 10 mm 3.5 µm WAT106127 WAT106128 30 x 50 mm 5 µm 186000235 186000237 3.9 x 20 mm 5 µm WAT054225 WAT054250 30 x 100 mm 5 µm 186000236 186000238 7.8 x 10 mm 7 µm 186000713 186000714
® 7.8 x 150 mm 7 µm WAT066288 WAT066285 Symmetry Capillary Columns 7.8 x 300 mm 7 µm WAT066235 WAT066225 19 x 10 mm 7 µm 186000717 186000718 Particle Part No. Part No. 19 x 150 mm 7 µm WAT066240 WAT066228 19 x 300 mm 7 µm WAT066245 WAT066230 Dimension Size C18 C8 0.32 x 50 mm 3.5 µm 186000945 186000946 Purification and Isolation Cartridge Column Holders 0.32 x 100 mm 3.5 µm 186000951 186000952 7.8 x 10 mm 5, 7 µm — 186000708 0.32 x 150 mm 3.5 µm 186000957 186000958 19 x 10 mm 5, 7 µm — 186000709 0.32 x 50 mm 5 µm 186000929 186000930 Replacement o-ring 7.8 mm, 2 pkg 700001019 0.32 x 100 mm 5 µm 186000935 186000936 Replacement o-ring 19 mm, 2 pkg 700001020 0.32 x 150 mm 5 µm 186000347 186000941
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 183 SymmetryShield™ Columns and Cartridges
SymmetryShield™ Columns SymmetryShield™ Column and Cartridge Column Method Validation Kits Particle Part No. Part No. Three Columns from Three Different Batches to Test Reproducibility. Dimension Size RP18 RP8 1.0 x 50 mm 3.5 µm 186000175 WAT106060 Particle Part No. Part No. 1.0 x 150 mm 3.5 µm 186000176 WAT106048 Dimension Type Size RP18 RP8 2.1 x 30 mm 3.5 µm 186000171 WAT106001 2.1 x 150 mm Column 3.5 µm 186000182 — 2.1 x 50 mm 3.5 µm 186000172 WAT094257 4.6 x 150 mm Column 3.5 µm 186000181 WAT094278 2.1 x 100 mm 3.5 µm 186000173 WAT058969 2.1 x 150 mm Column 5 µm 186000100 WAT094254 2.1 x 150 mm 3.5 µm 186000174 WAT106008 3.0 x 150 mm Column 5 µm - WAT094251 3.0 x 100 mm 3.5 µm 186000700 186000703 3.9 x 150 mm Column 5 µm 186000104 WAT210594 3.0 x 150 mm 3.5 µm 186000699 186000702 4.6 x 150 mm Column 5 µm 186000103 WAT210588 4.6 x 50 mm 3.5 µm 186000177 WAT094260 4.6 x 250 mm Column 5 µm 186000102 WAT210591 4.6 x 75 mm 3.5 µm 186000178 WAT094263 4.6 x 100 mm 3.5 µm 186000179 WAT094266 3.9 x 150 mm Cartridge* 5 µm 186000105 WAT210582 4.6 x 150 mm 3.5 µm 186000180 WAT094269 4.6 x 150 mm Cartridge* 5 µm 186000101 WAT210585 4.6 x 250 mm Cartridge* 5 µm 186000114 WAT210579 2.1 x 50 mm 5 µm 186000217 186000223 2.1 x 150 mm 5 µm 186000111 WAT094245 * Require endfittings, see Page 186 3.0 x 150 mm 5 µm 186000692 WAT094243 3.0 x 250 mm 5 µm 186000693 186000694 SymmetryShield™ Columns for Purification and Isolation 3.9 x 150 mm 5 µm 186000108 WAT200655 4.6 x 50 mm 5 µm 186000218 186000224 4.6 x 150 mm 5 µm 186000109 WAT200662 Particle Part No. Part No. 4.6 x 250 mm 5 µm 186000112 WAT200670 Dimension Size RP18 RP8 19 x 10 mm 5 µm 186001835 186001841 ™ 19 x 50 mm 5 µm 186001836 186001842 SymmetryShield Cartridge Columns (Requires endfittings, see Page 186) 19 x 100 mm 5 µm 186001837 186001843 19 x 150 mm 5 µm 186001838 186001844 Particle Part No. Part No. 19 x 150 mm 7 µm 186001839 186001845 Dimension Size RP RP 18 8 19 x 300 mm 7 µm 186001840 186001846 2.1 x 50 mm 3.5 µm 186000168 186000147 Purification and Isolation Cartridge Column Holders 2.1 x 100 mm 3.5 µm 186000167 186000146 2.1 x 150 mm 3.5 µm 186000166 186000145 7.8 x 10 mm 5, 7 µm — 186000708 4.6 x 75 mm 3.5 µm 186000183 WAT094272 19 x 10 mm 5, 7 µm — 186000709 4.6 x 100 mm 3.5 µm 186000170 WAT094275 Replacement o-ring 7.8 mm, 2 pkg 700001019 3.9 x 50 mm 5 µm — WAT094248 Replacement o-ring 19 mm, 2 pkg 700001020 3.9 x 150 mm 5 µm 186000106 WAT200658 4.6 x 150 mm 5 µm 186000110 WAT200665 4.6 x 250 mm 5 µm 186000113 WAT200661 Symmetry300™ Columns and Cartridges SymmetryShield™ Sentry™ Guard Columns (2 per pack) (Requires Sentry™ Guard Holders, see Page 186) Symmetry300™ Analytical Columns Particle Part No. Part No. Dimension Size RP18 RP8 Particle Part No.Part No. Dimension Size C C 2.1 x 10 mm 3.5 µm 186000169 WAT106129 18 4 3.9 x 20 mm 3.5 µm 186000701 186000704 1.0 x 150 mm 3.5 µm 186000185 186000276 3.9 x 20 mm 5 µm 186000107 WAT200675 2.1 x 50 mm 3.5 µm 186000187 186000277 2.1 x 100 mm 3.5 µm 186000188 186000278 SymmetryShield™ Capillary Columns 2.1 x 150 mm 3.5 µm 186000200 186000279 4.6 x 50 mm 3.5 µm 186000201 186000280 4.6 x 75 mm 3.5 µm 186000189 186000281 Particle Part No. Part No. 4.6 x 100 mm 3.5 µm 186000190 186000282 Dimension Size RP RP 18 8 4.6 x 150 mm 3.5 µm 186000197 186000283 0.32 x 50 mm 3.5 µm 186000947 186000948 2.1 x 150 mm 5 µm WAT106172 186000285 0.32 x 100 mm 3.5 µm 186000953 186000954 3.9 x 150 mm 5 µm WAT106154 186000286 0.32 x 150 mm 3.5 µm 186000959 186000960 4.6 x 50 mm 5 µm WAT106209 186000287 0.32 x 50 mm 5 µm 186000931 186000932 4.6 x 150 mm 5 µm WAT106157 186000288 0.32 x 100 mm 5 µm 186000937 186000938 4.6 x 250 mm 5 µm WAT106151 186000289 0.32 x 150 mm 5 µm 186000942 186000943
184 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. Symmetry300™ Cartridge Columns (Requires endfittings, see Page 186) Symmetry300™ Column and Cartridge Column Method Validation Kits Particle Part No. Three Columns from Three Different Batches to Test Reproducibility. Dimension Size C18 2.1 x 50 mm 3.5 µm 186000199 Particle Part No. Part No. 2.1 x 100 mm 3.5 µm 186000191 Dimension Type Size C18 C4 2.1 x 150 mm 3.5 µm 186000196 4.6 x 75 mm 3.5 µm 186000192 2.1 x 150 mm Column 3.5 µm 186000194 186000290 4.6 x 100 mm 3.5 µm 186000193 4.6 x 150 mm Column 3.5 µm 186000195 186000291 3.9 x 150 mm 5 µm WAT106169 2.1 x 150 mm Column 5 µm WAT106193 186000292 4.6 x 150 mm 5 µm WAT106163 3.9 x 150 mm Column 5 µm WAT106187 186000293 4.6 x 250 mm 5 µm WAT106160 4.6 x 150 mm Column 5 µm WAT106190 186000294 4.6 x 250 mm Column 5 µm WAT106184 186000295
3.9 x 150 mm Cartridge* 5 µm WAT106181 — ™ ™ Symmetry300 Sentry Guard Columns (2 per pack) 4.6 x 150 mm Cartridge* 5 µm WAT106175 — (Requires Sentry™ Guard Holders, see Page 186) 4.6 x 250 mm Cartridge* 5 µm WAT106178 —
* Require endfittings, see Page 186 Particle Part No. Part No. Dimension Size C18 C4 2.1 x 10 mm 3.5 µm 186000198 186000275 Symmetry300™ Columns for Purification and Isolation 3.9 x 20 mm 5 µm WAT106166 186000284 Particle Part No. Dimension Size C18 Symmetry300™ Capillary Columns 19 x 10 mm 5 µm 186001847 19 x 50 mm 5 µm 186001848 Particle Part No. Part No. 19 x 100 mm 5 µm 186001849 Dimension Size C18 C4 19 x 150 mm 5 µm 186001850 0.32 x 50 mm 3.5 µm 186000949 186000950 Purification and Isolation Cartridge Column Holders 0.32 x 100 mm 3.5 µm 186000955 186000956 7.8 x 10 mm 186000708 0.32 x 150 mm 3.5 µm 186000961 186000962 19 x 10 mm 186000709 0.32 x 50 mm 5 µm 186000933 186000934 Replacement o-ring 7.8 mm, 2 pkg 700001019 0.32 x 100 mm 5 µm 186000939 186000940 Replacement o-ring 19 mm, 2 pkg 700001020 0.32 x 150 mm 5 µm 186000348 186000944
™ ™ Symmetry IS™ Columns Opti-Pak Symmetry300 C18 trap columns (5 per pack)
Particle Symmetry300™ Particle Symmetry® Symmetry® Dimension Size C18 Dimension Size C18 C8 0.35 x 5 mm 5 µm 186001492 2.1 x 20 mm 3.5 µm 186002066 186002067 2.1 x 20 mm 3.5 µm 186002070 186002071 3.0 x 20 mm 3.5 µm 186002074 186002075 3.0 x 20 mm 5 µm 186002078 186002079 3.9 x 20 mm 5 µm 186002082 186002083 3.9 x 20 mm 5 µm 186002086 186002087 4.6 x 20 mm 5 µm 186002090 186002091 4.6 x 20 mm 5 µm 186002094 186002095
SymmetryShield IS™ Columns
Particle Symmetry® Symmetry® Dimension Size RP18 RP8 2.1 x 20 mm 3.5 µm 186002068 186002069 2.1 x 20 mm 3.5 µm 186002072 186002073 3.0 x 20 mm 3.5 µm 186002076 186002077 3.0 x 20 mm 5 µm 186002080 186002081 3.9 x 20 mm 5 µm 186002084 186002085 3.9 x 20 mm 5 µm 186002088 186002089 4.6 x 20 mm 5 µm 186002092 186002093 4.6 x 20 mm 5 µm 186002096 186002097
Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. 185 Cartridge and Guard Columns
Waters Cartridge Column Waters Sentry™ Guard Column and Universal Guard Holder Waters cartridge system requires re-useable endfittings. These cartridge endfit- tings need to be ordered when purchasing a Waters HPLC cartridge column Waters offers a line of Sentry™ Guard columns that contain the same high for the first time. These cartridge columns should be connected to your HPLC performance packing materials as all of the Waters analytical columns. instrument using Waters standard connectors. Developed for customers needing increased capacity for biological fluid clean- up and/or temperature control, the Sentry™ Guard column is available in two holder designs--one to be used as an integrated part of the Waters steel Connector C-Clip Endfitting cartridge column with reusable endfitting, the other for use with any HPLC WAT037525 column. Both are installed without tools.
Cartridge Sentry™ Guard Column Retaining Groove Nut
Disposable Cartridge Integrated Guard Holder
Integrated Sentry™ Guard Holder to go with cartridge end-fittings (see above) Waters Cartridge Column Universal Guard Holder 3.0 x 20 mm, 3.9 x 20 mm – use Part Number WAT046905 Reusable End Connectors Universal Sentry™ Guard Holder (Use on any column) Cartridge End-Fittings 2.1 x 10 mm use Part Number WAT097958 2.1 x 50 mm, 2.1 x 100 mm, 2.1 x 150 mm, 2.1 x 250 mm use Part Number 700000117 2.1 x 20 mm use Part Number 186000262 3.0 x 50 mm, 3.0 x 100 mm, 3.0 x 150 mm, 3.0 x 250 mm use Part Number WAT037525 3.0 x 20 mm use Part Number WAT046910 3.9 x 50 mm, 3.9 x 100 mm, 3.9 x 150 mm, 3.9 x 250 mm use Part Number WAT037525 3.9 x 20 mm use Part Number WAT046910 Sentry™ Guard Column 4.6 x 50 mm, 4.6 x 100 mm, 4.6 x 150 mm, 4.6 x 250 mm use Part Number WAT037525 4.6 x 20 mm use Part Number WAT046910
186 Waters, Symmetry, SymmetryShield, Sentry, SymmetryPrep, Platform LC, Quattro Ultima, IS, Oasis and Alliance are trademarks of Waters Corporation. ©2003 Waters Corporation. visit us on the internet: http://www.waters.com
HOW TO REACH US
Australia: France: The Netherlands: Spain: Waters Australia Pty. Limited Waters S.A Waters Chromatography B.V. Waters Chromatografia S.A. Unit 3, 38-46 South Street B.P. 608, 78056 Saint-Quentin Florijnstraat 19 Entenza 24- Planta Baja P.O Box 84, Rydalmere BC NSW 1701 En Yvelines, Cedex Postbus 215 08015 Barcelona Tel: (02) 9933 1777 Tel: 1 3048 7200 4870 AH Etten-Leur N.B. Tel: 34 93 600 93 00 Fax: (02) 9898 1455 Fax: 1 3048 7211 Tel: 31 076 508 7200 Fax: 34 93 325 98 96 Fax: 31 076 508 7280 Austria and European Export Germany: Sweden: (Central Europe, CIS, Middle East, Waters GmbH Norway: Waters Sverige AB India and India Subcontinent: Hauptstrasse 87 Waters AS Box 485, Turebergsvagen 3 Waters Ges.m.b.H. D-65760 Eschborn Hvamstubben 17 S-191 24 Sollentuna Hietzinger Haupstrasse 145 Tel: 49 6196 400600 N-2013 Skjetten Tel: (46) 8 555 11 500 A-1130 Vienna, Austria Fax: 49 6196 482388 Tel: 47 6 384 6050 Fax: (46) 8 555 11 520 Tel: 43 1 877 18 07 Fax: 47 6 384 6051 Hungary: Switzerland: Fax: 43 1 877 18 08 Waters kft People’s Republic of China Waters AG Belgium and Luxemburg: Vaci ut 202 Waters China Ltd Dorfstrasse 10 Waters S.A.-N.V. H-1138 Budapest Representative Office 5102 Rupperswil Raketstraat 60 Tel: 36 1 350 5086 Rm 301-401, Tower D Tel: 41 62 889 2030 Rue de la Fusee 60 Fax: 36 1 350 5087 No 5 Sanlitun Xiwujie Fax: 41 62 889 2059 1130 Brussels, Belgium Chaoyang District India: Taiwan: Tel: 32 2 726 1000 Beijing 100005, PR China Waters Pvt. Ltd. Waters Asia Ltd. Fax: 32 2 726 1100 Tel: 86 10 8451 8918 Taiwan Branch No. 36A, II Phase Fax: 86 10 8451 8928 Brazil: Peenya Industrial Area 4F-3, 23 Chang An East Rd., Waters Comercial LTDA Bangalore 560 058 Poland: Section 1, Taipei, Taiwan, R.O.C. Avenida Morumbi, Tel: 91 (80) 837 1900 Waters Sp z.o.o Tel: 02-2543-1898 8411 - 1o. e 7o. andares Fax: 91 (80) 839 2157 ul. Lekykarska 25 m 21 Fax: 02-2543-1918 04703-004, Sao Paulo, SP 01-687 Warszawa Ireland: United Kingdom: Tel: 55 11 5543 7788 Tel: 48 22 833 4400 Waters Chromatography Ireland Ltd Waters Ltd. Fax: 55 11 5093 6413 Fax: 48 22 833 0987 Unit 3.1 Woodford Business Park 730-740 Centennial Court Canada: Santry Puerto Rico: Centennial Park, Elstree, Waters Limited Dublin 9, Eire Waters Technologies Corporation Hertfordshire WD6 3SZ 6427 Northam Drive, Tel: (00353) 1 448 1500 P. O . Box 6870 United Kingdom Mississauga Fax: (00353) 1 448 1510 Urb. San Alfonso Tel: 44 208 238 6100 Ontario L4V 1H9 Canada Degetau Ave. No. A-1 Suite 104 Fax: 44 208 207 7070 Italy: Tel: 800 252 4752 Caguas, Puerto Rico 00726 Waters S.P.A. All Other Countries: Fax: 905 678 9237 Tel: 787 747 8445 Via Achille Grandi, 27 Fax: 787 747 8448 Waters Corporation Czech Republic: 20090 Vimodrone MI 34 Maple Street Waters Ges.m.b.H Tel: 39 02 274 211 Russia/CIS: Milford, MA 01757 USA Psohlavcu 43 Fax: 39 02 250 1827 Waters Ges.m.b.H. Tel: 508 478 2000 147 00 Prague 4 Representation Office Japan Nihon Waters K.K. 800 252 4752 Tel: 42 02 617 11384-5 ul. Miklukho-Maklaia 16/10 No 5. Koike Building Fax: 508 872 1990 Fax: 42 02 617 11386 117871 Moscow 1-3-12 Kita-Shinagawa 1-chome Tel: 7 095 931 9193 http://www.waters.com Denmark: Shinagawa-ku, Tokyo 140-0001 Fax: 7 095 336 7000 Waters A/S Tel: 81 3 3471 7191 On-Line Store—click on c.shop™ Baldersbuen 46 Fax: 81 3 3471 7118 Singapore: 2640 Hedehusene Waters Asia Ltd. Mexico: Tel: 45 46 59 8080 (Asia Headquarters) Waters S.A. DE C.V. Fax: 45 46 59 8585 396 Alexandra Road Adolfo Prieto No. 1655 #04-06 BP Tower Finland: Colonia del Valle Singapore 119954 Waters Oy Mexico, D.F 03100 Tel: 65 278 7997 Kuparitie 1 Tel: 5255 5524 7636 Fax: 65 278 7557 00440 Helsinki Fax: 5255 5524 9376 Tel: (09) 506 4140 Fax: (09) 506 41411
©2003 Waters Corporation, 6/03 720000593EN